Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

COVID-19

Free Subscription Articles published in JAMA Retrieve available abstracts of 483 articles: HTML format

Single Articles

November 2025
1. PANT S
   2024-2025 COVID-19 Vaccines Protected Against JN.1 Subvariants.
   JAMA. 2025 Nov 14. doi: 10.1001/jama.2025.19733.
   PubMed    
   
   
   
2. FRIEDEN TR, Schaffner W, Sharfstein JM
   CDC's Failure to Recommend COVID-19 Vaccination-"Shared Clinical Decision-Making" Is Abdication of Responsibility.
   JAMA. 2025 Nov 13. doi: 10.1001/jama.2025.22473.
   PubMed    
   
   
   
3. PANT S
   New COVID-19 Vaccination Guidelines for Immunocompromised Individuals.
   JAMA. 2025 Nov 7. doi: 10.1001/jama.2025.19727.
   PubMed    
   
   
   October 2025
4. PANT S
   First-Trimester COVID-19 Vaccination Not Associated With Congenital Risks.
   JAMA. 2025 Oct 31. doi: 10.1001/jama.2025.17533.
   PubMed    
   
   
   
5. SCHWANDT H, Kowarski J, Woolf SH
   Life Expectancy After the COVID-19 Pandemic-Reply.
   JAMA. 2025 Oct 27. doi: 10.1001/jama.2025.16405.
   PubMed    
   
   
   
6. WILSON KT, Esposito ML, Martinez A
   Life Expectancy After the COVID-19 Pandemic.
   JAMA. 2025 Oct 27. doi: 10.1001/jama.2025.16403.
   PubMed    
   
   
   
7. ABBASI J
   New Guidance on Cardiovascular Disease and COVID-19-From Infection to Long COVID to Vaccination.
   JAMA. 2025 Oct 24. doi: 10.1001/jama.2025.18834.
   PubMed    
   
   
   
8. SAUGEL B, Meidert AS, Brunkhorst FM, Bischoff R, et al
   Individualized Perioperative Blood Pressure Management in Patients Undergoing Major Abdominal Surgery: The IMPROVE-multi Randomized Clinical Trial.
   JAMA. 2025 Oct 12:e2517235. doi: 10.1001/jama.2025.17235.
   PubMed     Abstract available
   
   
   
9. ANDERER S
   COVID-19 Linked to Lasting and Underrecognized Smell Impairment.
   JAMA. 2025 Oct 10. doi: 10.1001/jama.2025.17491.
   PubMed    
   
   
   
10. SHAH J
    Through the Glass.
    JAMA. 2025 Oct 9. doi: 10.1001/jama.2025.18165.
    PubMed    
    
    
    September 2025
11. ANDERER S
    Updated COVID-19 Vaccine Generates Strong Immune Response.
    JAMA. 2025 Sep 26. doi: 10.1001/jama.2025.13887.
    PubMed    
    
    
    
12. ANDERER S
    Nasal Spray May Help Prevent COVID-19 Infection.
    JAMA. 2025 Sep 19. doi: 10.1001/jama.2025.13883.
    PubMed    
    
    
    
13. RUDMAN SPERGEL AK, Callendret B, Kostanyan L
    Influenza and COVID-19 Multicomponent Vaccine in Adults-Reply.
    JAMA. 2025 Sep 8. doi: 10.1001/jama.2025.12225.
    PubMed    
    
    
    
14. LIU Z, Zhang L, Jiang M
    Influenza and COVID-19 Multicomponent Vaccine in Adults.
    JAMA. 2025 Sep 8. doi: 10.1001/jama.2025.12222.
    PubMed    
    
    
    
15. ANDERER S
    Breaking From CDC, ACOG Continues Recommending COVID-19 Vaccine During Pregnancy.
    JAMA. 2025 Sep 5. doi: 10.1001/jama.2025.16943.
    PubMed    
    
    
    August 2025
16. SURIE D, Self WH, Yuengling KA, Lauring AS, et al
    RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons.
    JAMA. 2025 Aug 30:e2515896. doi: 10.1001/jama.2025.15896.
    PubMed     Abstract available
    
    
    
17. ANDERER S
    COVID-19, Flu May Reawaken Dormant Cancer Cells.
    JAMA. 2025 Aug 29. doi: 10.1001/jama.2025.14772.
    PubMed    
    
    
    
18. ANDERER S
    COVID-19 Vaccines Averted 2.5 Million Deaths, Mostly Among Older Adults.
    JAMA. 2025 Aug 15. doi: 10.1001/jama.2025.11001.
    PubMed    
    
    
    
19. TURNER NA, Hamasaki T, Doernberg SB, Lodise TP, et al
    Dalbavancin for Treatment of Staphylococcus aureus Bacteremia: The DOTS Randomized Clinical Trial.
    JAMA. 2025 Aug 13. doi: 10.1001/jama.2025.12543.
    PubMed     Abstract available
    
    
    
20. ANDERER S
    Booster Shots Help Prevent Severe COVID-19 in People With Cancer.
    JAMA. 2025 Aug 8. doi: 10.1001/jama.2025.10996.
    PubMed    
    
    
    
21. RUBIN R
    SARS-CoV-2 Variants Challenge Surveillance Efforts and COVID-19 Vaccines.
    JAMA. 2025 Aug 1. doi: 10.1001/jama.2025.12273.
    PubMed    
    
    
    July 2025
22. BAKER LD, Espeland MA, Whitmer RA, Snyder HM, et al
    Structured vs Self-Guided Multidomain Lifestyle Interventions for Global Cognitive Function: The US POINTER Randomized Clinical Trial.
    JAMA. 2025 Jul 28:e2512923. doi: 10.1001/jama.2025.12923.
    PubMed     Abstract available
    
    
    
23. SCHNEIDER L
    WHO Report Suggests Likely Zoonotic Origin of COVID-19, Doesn't Rule Out Lab Leak.
    JAMA. 2025 Jul 25. doi: 10.1001/jama.2025.10976.
    PubMed    
    
    
    
24. PRASAD V, Makary MA
    US FDA Safety Labeling Change for mRNA COVID-19 Vaccines.
    JAMA. 2025 Jul 14. doi: 10.1001/jama.2025.12675.
    PubMed    
    
    
    
25. RUBIN R
    The CDC No Longer Recommends COVID-19 Shots During Pregnancy-Now What?
    JAMA. 2025 Jul 11. doi: 10.1001/jama.2025.11889.
    PubMed    
    
    
    
26. SCHWANDT H, Currie J, von Wachter T, Kowarski J, et al
    The Failure of Life Expectancy to Fully Rebound to Prepandemic Levels.
    JAMA. 2025 Jul 9:e2510439. doi: 10.1001/jama.2025.10439.
    PubMed    
    
    
    
27. STAR J, Bandi P
    Cancer Screening After the Onset of the COVID-19 Pandemic-Reply.
    JAMA. 2025 Jul 7. doi: 10.1001/jama.2025.6934.
    PubMed    
    
    
    
28. WU G, Yin J, Huang Y
    Cancer Screening After the Onset of the COVID-19 Pandemic.
    JAMA. 2025 Jul 7. doi: 10.1001/jama.2025.6931.
    PubMed    
    
    
    June 2025
29. GRUNEBAUM A, Chervenak FA
    Professional Responsibility for COVID-19 Vaccination in Pregnancy.
    JAMA. 2025 Jun 25. doi: 10.1001/jama.2025.11328.
    PubMed    
    
    
    
30. GOSTIN LO, Reiss D, Offit PA
    Changed Recommendations for COVID-19 Vaccines for Children and Pregnant Women: A Failure of Process, Policy, and Science.
    JAMA. 2025 Jun 13. doi: 10.1001/jama.2025.10658.
    PubMed    
    
    
    
31. ZETTLER PJ, Cha S, Despres S, Lurie P, et al
    FDA Review of Novavax's COVID-19 Vaccine-Regulatory Integrity and Deviations From Standard Practice.
    JAMA. 2025 Jun 9. doi: 10.1001/jama.2025.9898.
    PubMed    
    
    
    
32. NGUYEN T, Whaley C, Simon KI, Cantor J, et al
    Health Care Workforce Recovery After the End of the COVID-19 Emergency.
    JAMA. 2025 Jun 5. doi: 10.1001/jama.2025.8588.
    PubMed    
    
    
    May 2025
33. RUDMAN SPERGEL AK, Wu I, Deng W, Cardona J, et al
    Immunogenicity and Safety of Influenza and COVID-19 Multicomponent Vaccine in Adults >/=50 Years: A Randomized Clinical Trial.
    JAMA. 2025 May 7:e255646. doi: 10.1001/jama.2025.5646.
    PubMed     Abstract available
    
    
    April 2025
34. KIANG MV, Bubar KM, Maldonado Y, Hotez PJ, et al
    Modeling Reemergence of Vaccine-Eliminated Infectious Diseases Under Declining Vaccination in the US.
    JAMA. 2025 Apr 24. doi: 10.1001/jama.2025.6495.
    PubMed     Abstract available
    
    
    
35. MOIN EE, Seewald NJ, Halpern SD
    Use of Life Support and Outcomes Among Patients Admitted to Intensive Care Units.
    JAMA. 2025 Apr 14:e252163. doi: 10.1001/jama.2025.2163.
    PubMed     Abstract available
    
    
    March 2025
36. LAURING AS, Edson C, Surie D, Dawood FS, et al
    Genomic Characterization of RSV in the US by Vaccination Status.
    JAMA. 2025 Mar 10. doi: 10.1001/jama.2025.1225.
    PubMed    
    
    
    
37. STAR J, Han X, Smith RA, Schafer EJ, et al
    Cancer Screening 3 Years After the Onset of the COVID-19 Pandemic.
    JAMA. 2025 Mar 5:e250902. doi: 10.1001/jama.2025.0902.
    PubMed    
    
    
    February 2025
38. HANLON P, Butterly E, Wei L, Wightman H, et al
    Age and Sex Differences in Efficacy of Treatments for Type 2 Diabetes: A Network Meta-Analysis.
    JAMA. 2025 Feb 3:e2427402. doi: 10.1001/jama.2024.27402.
    PubMed     Abstract available
    
    
    January 2025
39. ANDERER S
    COVID-19 Tied to Long-Term Kidney Function Decline.
    JAMA. 2025 Jan 24. doi: 10.1001/jama.2024.28058.
    PubMed    
    
    
    December 2024
40. RUBIN R
    In Search of COVID-19 Vaccines That Elicit Mucosal Immunity and Stop Transmission.
    JAMA. 2024 Dec 20. doi: 10.1001/jama.2024.23627.
    PubMed    
    
    
    
41. GENG LN, Erlandson KM, Hornig M, Letts R, et al
    2024 Update of the RECOVER-Adult Long COVID Research Index.
    JAMA. 2024 Dec 18. doi: 10.1001/jama.2024.24184.
    PubMed     Abstract available
    
    
    
42. ANDERER S
    New Research Suggests Increased Risk of Some Autoimmune Disorders After COVID-19.
    JAMA. 2024 Dec 13. doi: 10.1001/jama.2024.24894.
    PubMed    
    
    
    
43. ANDERER S
    Trial Shows It's Safe to Get COVID-19, Flu Vaccines at the Same Time.
    JAMA. 2024 Dec 13. doi: 10.1001/jama.2024.24891.
    PubMed    
    
    
    
44. MAIA IS, Kawano-Dourado L, Tramujas L, de Oliveira NE, et al
    High-Flow Nasal Oxygen vs Noninvasive Ventilation in Patients With Acute Respiratory Failure: The RENOVATE Randomized Clinical Trial.
    JAMA. 2024 Dec 10. doi: 10.1001/jama.2024.26244.
    PubMed     Abstract available
    
    
    
45. ANDERER S
    CDC Recommends Second COVID-19 Vaccine Dose for Older Adults.
    JAMA. 2024 Dec 6. doi: 10.1001/jama.2024.24258.
    PubMed    
    
    
    November 2024
46. RUBIN R
    What to Know About XEC, the New SARS-CoV-2 Variant Expected to Dominate Winter's COVID-19 Wave.
    JAMA. 2024 Nov 22. doi: 10.1001/jama.2024.24481.
    PubMed    
    
    
    
47. ANDERER S
    Early COVID-19 Infections Linked With Higher Heart Attack, Stroke Risk.
    JAMA. 2024 Nov 15. doi: 10.1001/jama.2024.23045.
    PubMed    
    
    
    
48. ANDERER S
    FDA Authorizes First At-Home COVID-19 and Flu Combo Test.
    JAMA. 2024 Nov 8. doi: 10.1001/jama.2024.22561.
    PubMed    
    
    
    October 2024
49. TADROUS M, Callaway Kim K, Hernandez I, Rothenberger SD, et al
    Differences in Drug Shortages in the US and Canada.
    JAMA. 2024 Oct 31. doi: 10.1001/jama.2024.17688.
    PubMed     Abstract available
    
    
    
50. ANDERER S
    HHS Will Provide Free US-Made COVID-19 Tests to Households.
    JAMA. 2024 Oct 25. doi: 10.1001/jama.2024.21819.
    PubMed    
    
    
    
51. 
    Audio Highlights: September 14-20, 2024.
    JAMA. 2024;332:e2318402.
    PubMed    
    
    
    
52. HABIB AR, Ijaz N
    Public Health Crisis in Gaza-Reply.
    JAMA. 2024;332:1305-1306.
    PubMed    
    
    
    
53. PATEL P, Wentworth DE, Daskalakis D
    COVID-19 Therapeutics for Nonhospitalized Older Adults.
    JAMA. 2024 Oct 7. doi: 10.1001/jama.2024.16460.
    PubMed    
    
    
    September 2024
54. ANDERER S
    Caseload Strain Contributed to 1 in 5 COVID-19 Deaths at US Hospitals.
    JAMA. 2024 Sep 27. doi: 10.1001/jama.2024.19687.
    PubMed    
    
    
    
55. ANDERER S
    FDA Approves Updated COVID-19 Vaccines.
    JAMA. 2024 Sep 20. doi: 10.1001/jama.2024.19127.
    PubMed    
    
    
    
56. LIM JK, Ramgopal S, Hoffmann JA, Lorenz D, et al
    Characteristics and Trends of Prehospital Encounters for Opioid Overdoses Among US Youth, 2018-2022.
    JAMA. 2024 Sep 18:e2417341. doi: 10.1001/jama.2024.17341.
    PubMed    
    
    
    
57. AMBA V, Cooper MSL, Sommers BD
    History Repeats-The Election Battle for Medicaid in 2024.
    JAMA. 2024;332:867-868.
    PubMed    
    
    
    
58. VAUGHN VM, Dickson RP, Horowitz JK, Flanders SA, et al
    Community-Acquired Pneumonia: A Review.
    JAMA. 2024 Sep 16. doi: 10.1001/jama.2024.14796.
    PubMed     Abstract available
    
    
    
59. ANDERER S
    Combo COVID-19 and Flu mRNA Vaccine Falls Short of Total Flu Protection.
    JAMA. 2024 Sep 13. doi: 10.1001/jama.2024.18194.
    PubMed    
    
    
    
60. BOCK A
    New Guidance Helps Clinicians Use Pemivibart to Protect Immunocompromised Patients From COVID-19.
    JAMA. 2024 Sep 13. doi: 10.1001/jama.2024.18589.
    PubMed    
    
    
    
61. ANDERER S
    CDC: Overall Deaths, Especially From COVID-19, Lower in 2023.
    JAMA. 2024 Sep 6. doi: 10.1001/jama.2024.17606.
    PubMed    
    
    
    
62. RUBIN R
    The Latest Research About Paxlovid: Effectiveness, Access, and Possible Long COVID Benefits.
    JAMA. 2024 Sep 6. doi: 10.1001/jama.2024.16432.
    PubMed    
    
    
    
63. SURIE D, Self WH, Zhu Y, Yuengling KA, et al
    RSV Vaccine Effectiveness Against Hospitalization Among US Adults 60 Years and Older.
    JAMA. 2024 Sep 4:e2415775. doi: 10.1001/jama.2024.15775.
    PubMed    
    
    
    
64. 
    Audio Highlights.
    JAMA. 2024;332:e2318388.
    PubMed    
    
    
    August 2024
65. WOOLF SH
    Increasing Mortality Rates in the US, but Not From COVID-19.
    JAMA. 2024 Aug 29. doi: 10.1001/jama.2024.13626.
    PubMed    
    
    
    
66. SEMENZATO L, Le Vu S, Botton J, Bertrand M, et al
    Long-Term Prognosis of Patients With Myocarditis Attributed to COVID-19 mRNA Vaccination, SARS-CoV-2 Infection, or Conventional Etiologies.
    JAMA. 2024 Aug 26:e2416380. doi: 10.1001/jama.2024.16380.
    PubMed     Abstract available
    
    
    
67. ANDERER S
    Widespread SARS-CoV-2 Exposure Among Wildlife in the US.
    JAMA. 2024 Aug 23. doi: 10.1001/jama.2024.15877.
    PubMed    
    
    
    
68. GROSS RS, Thaweethai T, Kleinman LC, Snowden JN, et al
    Characterizing Long COVID in Children and Adolescents.
    JAMA. 2024 Aug 21:e2412747. doi: 10.1001/jama.2024.12747.
    PubMed     Abstract available
    
    
    
69. AHMAD FB, Cisewski JA, Anderson RN
    Leading Causes of Death in the US, 2019-2023.
    JAMA. 2024 Aug 8. doi: 10.1001/jama.2024.15563.
    PubMed    
    
    
    
70. WARE LB, Files DC, Fowler A, Aboodi MS, et al
    Acetaminophen for Prevention and Treatment of Organ Dysfunction in Critically Ill Patients With Sepsis: The ASTER Randomized Clinical Trial.
    JAMA. 2024;332:390-400.
    PubMed     Abstract available
    
    
    
71. HARRIS E
    NIH Starts Testing Nasal COVID-19 Vaccine in US.
    JAMA. 2024 Aug 2. doi: 10.1001/jama.2024.13769.
    PubMed    
    
    
    July 2024
72. HARRIS E
    COVID-19 Vaccination in Early Pregnancy Not Linked to Birth Defects.
    JAMA. 2024 Jul 26. doi: 10.1001/jama.2024.13389.
    PubMed    
    
    
    
73. YOUMSHAJEKIAN L
    COVID-19 May Protect Against the Common Cold-Here's Why Knowing That Could Lead to Better Vaccines.
    JAMA. 2024 Jul 26. doi: 10.1001/jama.2024.13382.
    PubMed    
    
    
    
74. AGARWAL SD, Cook BL, Liebman JB
    Effect of Cash Benefits on Health Care Utilization and Health: A Randomized Study.
    JAMA. 2024 Jul 22:e2413004. doi: 10.1001/jama.2024.13004.
    PubMed     Abstract available
    
    
    
75. FRIEDL N, Sporreiter M, Winkler C, Heublein A, et al
    Progression From Presymptomatic to Clinical Type 1 Diabetes After COVID-19 Infection.
    JAMA. 2024 Jul 15:e2411174. doi: 10.1001/jama.2024.11174.
    PubMed    
    
    
    
76. HARRIS E
    Symptoms After COVID-19 Vaccination Tied to Higher Antibody Levels.
    JAMA. 2024 Jul 12. doi: 10.1001/jama.2024.12231.
    PubMed    
    
    
    
77. RUBIN R
    Picking the Optimal Variant to Target in Updated COVID-19 Vaccines Is Tricky.
    JAMA. 2024 Jul 12. doi: 10.1001/jama.2024.10992.
    PubMed    
    
    
    
78. HARRIS E
    Review Calls for Standardized Long COVID Definition.
    JAMA. 2024;332:97.
    PubMed    
    
    
    
79. FANG Z, Ahrnsbrak R, Rekito A
    Evidence Mounts That About 7% of US Adults Have Had Long COVID.
    JAMA. 2024;332:5-6.
    PubMed    
    
    
    June 2024
80. ZIMBROFF RM, Deardorff WJ, Song S, Nikolov MC, et al
    Use of a Financial Incentive Code for In-Home COVID-19 Vaccination of Homebound Older Adults.
    JAMA. 2024 Jun 20. doi: 10.1001/jama.2024.9673.
    PubMed    
    
    
    
81. PIRRACCHIO R, Venkatesh B, Legrand M
    Low-Dose Corticosteroids for Critically Ill Adults With Severe Pulmonary Infections: A Review.
    JAMA. 2024 Jun 12. doi: 10.1001/jama.2024.6096.
    PubMed     Abstract available
    
    
    
82. ABDUL-AZIZ MH, Hammond NE, Brett SJ, Cotta MO, et al
    Prolonged vs Intermittent Infusions of beta-Lactam Antibiotics in Adults With Sepsis or Septic Shock: A Systematic Review and Meta-Analysis.
    JAMA. 2024 Jun 12:e249803. doi: 10.1001/jama.2024.9803.
    PubMed     Abstract available
    
    
    
83. DEAN N, Amin AB
    Test-Negative Study Designs for Evaluating Vaccine Effectiveness.
    JAMA. 2024 Jun 12. doi: 10.1001/jama.2024.5633.
    PubMed    
    
    
    
84. VAN DER LINDEN S, Roozenbeek J
    "Inoculation" to Resist Misinformation.
    JAMA. 2024;331:1961-1962.
    PubMed    
    
    
    
85. ANGUS DC, Huang AJ, Lewis RJ, Abernethy AP, et al
    The Integration of Clinical Trials With the Practice of Medicine: Repairing a House Divided.
    JAMA. 2024 Jun 3. doi: 10.1001/jama.2024.4088.
    PubMed     Abstract available
    
    
    May 2024
86. HARRIS E
    Monoclonal Antibody Authorized to Protect At-Risk People From COVID-19.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8628.
    PubMed    
    
    
    
87. HARRIS E
    Lower Dose of Mpox Vaccine Was Safe, Effective.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8635.
    PubMed    
    
    
    
88. HARRIS E
    Microneedle Vaccine Patches Generated Immune Response in Children.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8629.
    PubMed    
    
    
    
89. BOCK A
    Researchers See Hope in Symptom-Guided Exercise for Long COVID With Postexertional Malaise.
    JAMA. 2024;331:1609-1611.
    PubMed    
    
    
    
90. DEVEREUX G, Cotton S, Nath M, McMeekin N, et al
    Bisoprolol in Patients With Chronic Obstructive Pulmonary Disease at High Risk of Exacerbation: The BICS Randomized Clinical Trial.
    JAMA. 2024 May 19. doi: 10.1001/jama.2024.8771.
    PubMed     Abstract available
    
    
    
91. RUBIN R
    Combined Vaccines Against COVID-19, Flu, and Other Respiratory Illnesses Could Soon Be Available.
    JAMA. 2024 May 17. doi: 10.1001/jama.2024.7370.
    PubMed    
    
    
    
92. XIE Y, Choi T, Al-Aly Z
    Mortality in Patients Hospitalized for COVID-19 vs Influenza in Fall-Winter 2023-2024.
    JAMA. 2024 May 15:e247395. doi: 10.1001/jama.2024.7395.
    PubMed    
    
    
    
93. 
    Audio Highlights.
    JAMA. 2024;331:e2318283.
    PubMed    
    
    
    
94. WEN X, Yan J, Zhu Z
    Apixaban to Prevent Recurrence After Cryptogenic Stroke.
    JAMA. 2024 May 13. doi: 10.1001/jama.2024.6848.
    PubMed    
    
    
    
95. HARRIS E
    National Academies Report: COVID-19 Vaccines Don't Cause Many Potential Harms.
    JAMA. 2024 May 10. doi: 10.1001/jama.2024.7724.
    PubMed    
    
    
    
96. HARRIS E
    Trials Will Evaluate Treatments for Long COVID Nervous System Problems.
    JAMA. 2024;331:1439-1440.
    PubMed    
    
    
    
97. AGRAWAL S, Ross JS, Ramachandran R
    Implications for Public Health Regulation if Chevron Deference Is Overturned.
    JAMA. 2024;331:1443-1444.
    PubMed    
    
    
    
98. CHESHIRE WP, Dudenkov DV, Munipalli B
    Tilt Table Testing.
    JAMA. 2024;331:1494-1495.
    PubMed    
    
    
    April 2024
99. HARRIS E
    WHO Launches Broad Coronavirus Surveillance Network.
    JAMA. 2024 Apr 26. doi: 10.1001/jama.2024.6724.
    PubMed    
    
    
    
100. ALLEN MR, Desai N, Namazi A, Leas E, et al
     Characteristics of X (Formerly Twitter) Community Notes Addressing COVID-19 Vaccine Misinformation.
     JAMA. 2024 Apr 24:e244800. doi: 10.1001/jama.2024.4800.
     PubMed    
     
     
     
101. HARRIS E
     Meta-Analysis: "Limited" Benefits to Rapid Viral Tests in EDs.
     JAMA. 2024;331:1355.
     PubMed    
     
     
     
102. HARRIS E
     Deaths From Excessive Drinking Rose in the US During Pandemic.
     JAMA. 2024;331:1355.
     PubMed    
     
     
     
103. IMPERIALE TF, Lavin P, Ransohoff DF
     Multitarget Stool RNA Testing.
     JAMA. 2024;331:1418.
     PubMed    
     
     
     
104. BAIRD G
     Multitarget Stool RNA Testing.
     JAMA. 2024;331:1418-1419.
     PubMed    
     
     
     
105. BARNELL EK, Lieberman DA
     Multitarget Stool RNA Testing-Reply.
     JAMA. 2024;331:1419-1420.
     PubMed    
     
     
     
106. HARRIS E
     Antidepressant Prescriptions for Female Teens Surged After Pandemic.
     JAMA. 2024;331:1266.
     PubMed    
     
     
     
107. HARRIS E
     COVID-19 Vaccination Linked With Lower Risk of Cardiac Problems.
     JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5152.
     PubMed    
     
     
     
108. ANDERER S
     Could "Empathetic Refutation" Help Clinicians Sway Vaccine Skeptics?
     JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.4493.
     PubMed    
     
     
     
109. DAWOOD FS, Payne AB, McMorrow ML
     Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus.
     JAMA. 2024 Apr 11. doi: 10.1001/jama.2024.5859.
     PubMed    
     
     
     
110. ANDERER S
     Study: 1 of Every 9 US Cancer Cases Missed During 2020 Pandemic.
     JAMA. 2024;331:1082.
     PubMed    
     
     
     
111. GUSSIN GM, McKinnell JA, Singh RD, Miller LG, et al
     Reducing Hospitalizations and Multidrug-Resistant Organisms via Regional Decolonization in Hospitals and Nursing Homes.
     JAMA. 2024 Apr 1:e242759. doi: 10.1001/jama.2024.2759.
     PubMed     Abstract available
     
     
     March 2024
112. HARRIS E
     COVID-19 Infection Tied to Slight Cognitive Deficits.
     JAMA. 2024 Mar 22. doi: 10.1001/jama.2024.2087.
     PubMed    
     
     
     
113. HARRIS E
     COVID-19 Associated With Higher Risk of Autoimmune Diseases.
     JAMA. 2024 Mar 22. doi: 10.1001/jama.2024.2092.
     PubMed    
     
     
     
114. LU Y, Matuska K, Nadimpalli G, Ma Y, et al
     Stroke Risk After COVID-19 Bivalent Vaccination Among US Older Adults.
     JAMA. 2024;331:938-950.
     PubMed     Abstract available
     
     
     
115. NIELSEN FM, Klitgaard TL, Siegemund M, Laake JH, et al
     Lower vs Higher Oxygenation Target and Days Alive Without Life Support in COVID-19: The HOT-COVID Randomized Clinical Trial.
     JAMA. 2024 Mar 19:e242934. doi: 10.1001/jama.2024.2934.
     PubMed     Abstract available
     
     
     
116. SCHWARTZSTEIN RM
     Oxygen Supplementation in COVID-19-How Much Is Enough?
     JAMA. 2024 Mar 19. doi: 10.1001/jama.2024.2935.
     PubMed    
     
     
     
117. HARRIS E
     CDC Tracking BA.2.87.1, New Omicron Subvariant With Potential to Evade Immunity.
     JAMA. 2024;331:907.
     PubMed    
     
     
     
118. ANDERER S
     CDC Recommends Additional COVID-19 Booster for Older Adults.
     JAMA. 2024 Mar 13. doi: 10.1001/jama.2024.2071.
     PubMed    
     
     
     
119. MCKENZIE C, Moore L, Borthwick M
     Vitamin C for Patients Hospitalized With COVID-19.
     JAMA. 2024;331:886.
     PubMed    
     
     
     
120. ADHIKARI NKJ, Lamontagne F
     Vitamin C for Patients Hospitalized With COVID-19-Reply.
     JAMA. 2024;331:886-887.
     PubMed    
     
     
     
121. HARRIS E
     Virtual Group Exercise Program Improved Long COVID Symptoms.
     JAMA. 2024;331:822.
     PubMed    
     
     
     
122. HARRIS E
     Better Outcomes When Kidney Damage Is From COVID-19.
     JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1574.
     PubMed    
     
     
     
123. HARRIS E
     HPV Vaccination Rates Stagnated During COVID-19 Pandemic.
     JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1569.
     PubMed    
     
     
     
124. HARRIS E
     Millions of US Children Experience Range of Long COVID Effects.
     JAMA. 2024;331:726.
     PubMed    
     
     
     February 2024
125. ANDERSSON NW, Thiesson EM, Hviid A
     Adverse Events After XBB.1.5-Containing COVID-19 mRNA Vaccines.
     JAMA. 2024 Feb 26:e241036. doi: 10.1001/jama.2024.1036.
     PubMed    
     
     
     
126. HARRIS E
     New Antiviral on the Horizon for Mild to Moderate COVID-19.
     JAMA. 2024 Feb 21. doi: 10.1001/jama.2024.0729.
     PubMed    
     
     
     
127. GRAETZ N, Hepburn P, Gershenson C, Porter SR, et al
     Examining Excess Mortality Associated With the COVID-19 Pandemic for Renters Threatened With Eviction.
     JAMA. 2024;331:592-600.
     PubMed     Abstract available
     
     
     
128. RUBIN R
     When It Comes to SARS-CoV-2 Clearance, People Who are Immunocompromised Are Not All Alike.
     JAMA. 2024 Feb 14. doi: 10.1001/jama.2024.1014.
     PubMed    
     
     
     
129. NORMAN M, Magnus MC, Soderling J, Juliusson PB, et al
     Neonatal Outcomes After COVID-19 Vaccination in Pregnancy.
     JAMA. 2024;331:396-407.
     PubMed     Abstract available
     
     
     
130. FELDSTEIN LR, Britton A, Grant L, Wiegand R, et al
     Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years.
     JAMA. 2024;331:408-416.
     PubMed     Abstract available
     
     
     January 2024
131. HARRIS E
     Missed Vaccine Doses Tied to Worse COVID-19 Outcomes.
     JAMA. 2024 Jan 31. doi: 10.1001/jama.2023.28340.
     PubMed    
     
     
     
132. RUBIN R
     Paxlovid Is Effective but Underused-Here's What the Latest Research Says About Rebound and More.
     JAMA. 2024 Jan 31. doi: 10.1001/jama.2023.28254.
     PubMed    
     
     
     
133. RUBIN R
     As COVID-19 Cases Surge, Here's What to Know About JN.1, the Latest SARS-CoV-2 "Variant of Interest".
     JAMA. 2024 Jan 12. doi: 10.1001/jama.2023.27841.
     PubMed    
     
     
     
134. RUBIN R
     From "Immunity Debt" to "Immunity Theft"-How COVID-19 Might Be Tied to Recent Respiratory Disease Surges.
     JAMA. 2024 Jan 10. doi: 10.1001/jama.2023.26608.
     PubMed    
     
     
     
135. KAPOOR N, Dietz C, Buettner BP
     An Incarcerated Individual With Weight Loss and Interstitial Pulmonary Infiltrates.
     JAMA. 2024 Jan 8. doi: 10.1001/jama.2023.24260.
     PubMed    
     
     
     
136. MARKS P, Califf R
     Is Vaccination Approaching a Dangerous Tipping Point?
     JAMA. 2024 Jan 5. doi: 10.1001/jama.2023.27685.
     PubMed    
     
     
     
137. HARRIS E
     Long COVID in Nursing Home Residents Manifests as Functional Decline.
     JAMA. 2024;331:15.
     PubMed    
     
     
     December 2023
138. HARRIS E
     Disproportionate Death Rates Reported in US Prisons Early in the COVID-19 Pandemic.
     JAMA. 2023 Dec 27. doi: 10.1001/jama.2023.25770.
     PubMed    
     
     
     
139. HARRIS E
     Using Throat Swabs Improved Sensitivity in Detecting SARS-CoV-2.
     JAMA. 2023 Dec 20. doi: 10.1001/jama.2023.25267.
     PubMed    
     
     
     
140. HARRIS E
     Program Offering Free COVID-19 and Flu Services Expands Nationwide.
     JAMA. 2023 Dec 20. doi: 10.1001/jama.2023.25268.
     PubMed    
     
     
     
141. HARRIS E
     Life Expectancy in US Climbed After Declines Related to COVID-19.
     JAMA. 2023 Dec 13. doi: 10.1001/jama.2023.24683.
     PubMed    
     
     
     
142. SURAN M
     Studies Investigate Whether Antivirals Like Paxlovid May Prevent Long COVID.
     JAMA. 2023 Dec 13. doi: 10.1001/jama.2023.24103.
     PubMed    
     
     
     
143. RUBIN R
     Up the Nose and Down the Windpipe May Be the Path to New and Improved COVID-19 Vaccines.
     JAMA. 2023 Dec 6. doi: 10.1001/jama.2023.0644.
     PubMed    
     
     
     
144. MATHEW P, Feldmann M
     Treatment of Adults Hospitalized With COVID-19 Pneumonia.
     JAMA. 2023;330:2122-2123.
     PubMed    
     
     
     
145. POWDERLY WG, LaVange L, Bozzette SA
     Treatment of Adults Hospitalized With COVID-19 Pneumonia-Reply.
     JAMA. 2023;330:2123.
     PubMed    
     
     
     
146. SCHMIDT M, Hajage D, Lebreton G, Dres M, et al
     Prone Positioning During Extracorporeal Membrane Oxygenation in Patients With Severe ARDS: The PRONECMO Randomized Clinical Trial.
     JAMA. 2023 Dec 1. doi: 10.1001/jama.2023.24491.
     PubMed     Abstract available
     
     
     November 2023
147. EASTMAN Q
     Study Shows Businesses Selling Unapproved Stem Cell Treatments Have Turned to Long COVID.
     JAMA. 2023 Nov 29. doi: 10.1001/jama.2023.23897.
     PubMed    
     
     
     
148. BERGMAN C
     Treatment of SARS-CoV-2 Infection in US Nursing Homes.
     JAMA. 2023;330:2021-2022.
     PubMed    
     
     
     
149. MCGARRY BE, Sommers BD, Barnett ML
     Treatment of SARS-CoV-2 Infection in US Nursing Homes-Reply.
     JAMA. 2023;330:2022.
     PubMed    
     
     
     
150. HARRIS E
     COVID Moonshot Drove Discovery of Potential COVID-19 Antivirals.
     JAMA. 2023 Nov 22. doi: 10.1001/jama.2023.22934.
     PubMed    
     
     
     
151. HARRIS E
     Smell, Taste Issues After Mild COVID-19 Resolve Over 3 Years.
     JAMA. 2023 Nov 22. doi: 10.1001/jama.2023.22930.
     PubMed    
     
     
     
152. HARRIS E
     Long COVID Linked With Viral Persistence, Serotonin Decline.
     JAMA. 2023;330:1827.
     PubMed    
     
     
     
153. HARRIS E
     Audit Finds US National Stockpile "Was Not Equipped" for the Pandemic.
     JAMA. 2023;330:1828.
     PubMed    
     
     
     
154. STEWART TG, Rebolledo PA, Mourad A, Lindsell CJ, et al
     Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19: The ACTIV-6 Randomized Clinical Trial.
     JAMA. 2023 Nov 17:e2323363. doi: 10.1001/jama.2023.23363.
     PubMed     Abstract available
     
     
     
155. HARRIS E
     Combined COVID-19, Flu Vaccine Candidate Headed to Phase 3 Trials.
     JAMA. 2023 Nov 15. doi: 10.1001/jama.2023.22353.
     PubMed    
     
     
     
156. HARRIS E
     Convalescent Plasma Lowered Risk of Death in COVID-19 ARDS.
     JAMA. 2023 Nov 8. doi: 10.1001/jama.2023.21872.
     PubMed    
     
     
     
157. HARRIS E
     HRSA Study: US Abortions Decreased 14% During COVID-19.
     JAMA. 2023 Nov 1. doi: 10.1001/jama.2023.21178.
     PubMed    
     
     
     October 2023
158. ADHIKARI NKJ, Hashmi M, Tirupakuzhi Vijayaraghavan BK, Haniffa R, et al
     Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials.
     JAMA. 2023 Oct 25:e2321407. doi: 10.1001/jama.2023.21407.
     PubMed     Abstract available
     
     
     
159. JABALEY CS, Coopersmith CM
     Vitamin C for Patients With COVID-19: More Evidence of Lack of Efficacy in Patients With Sepsis.
     JAMA. 2023 Oct 25. doi: 10.1001/jama.2023.18592.
     PubMed    
     
     
     
160. HARRIS E
     US Survey: About 7% of Adults, 1% of Children Have Had Long COVID.
     JAMA. 2023;330:1516.
     PubMed    
     
     
     
161. HARRIS E
     COVID-19 Hospitalizations Up Among Older Adults.
     JAMA. 2023 Oct 18. doi: 10.1001/jama.2023.19796.
     PubMed    
     
     
     
162. HARRIS E
     Previous COVID-19 Linked With Autoimmune Conditions.
     JAMA. 2023 Oct 18. doi: 10.1001/jama.2023.19798.
     PubMed    
     
     
     
163. BATRA A, Nath A, Koralnik IJ
     Postacute Sequelae of SARS-CoV-2 Infection.
     JAMA. 2023;330:1491-1492.
     PubMed    
     
     
     
164. THAWEETHAI T, Foulkes AS
     Postacute Sequelae of SARS-CoV-2 Infection-Reply.
     JAMA. 2023;330:1492.
     PubMed    
     
     
     
165. HARRIS E
     Exercise Programs Might Improve Long COVID.
     JAMA. 2023;330:1421.
     PubMed    
     
     
     
166. SIEGAL DM, Belley-Cote EP, Lee SF, Hill S, et al
     Small-Volume Blood Collection Tubes to Reduce Transfusions in Intensive Care: The STRATUS Randomized Clinical Trial.
     JAMA. 2023 Oct 12. doi: 10.1001/jama.2023.20820.
     PubMed     Abstract available
     
     
     
167. RAASVELD SJ, de Bruin S, Reuland MC, van den Oord C, et al
     Red Blood Cell Transfusion in the Intensive Care Unit.
     JAMA. 2023 Oct 12. doi: 10.1001/jama.2023.20737.
     PubMed     Abstract available
     
     
     
168. HARRIS E
     Changes in SARS-CoV-2 Sequence Linked With Antiviral Use.
     JAMA. 2023 Oct 4. doi: 10.1001/jama.2023.19202.
     PubMed    
     
     
     September 2023
169. CHEW KW, Malani PN, Gandhi RT
     COVID-19 Therapeutics for Nonhospitalized Patients-Updates and Future Directions.
     JAMA. 2023 Sep 29. doi: 10.1001/jama.2023.19542.
     PubMed    
     
     
     
170. HARRIS E
     Some People Still Have Long COVID Symptoms After 2 Years.
     JAMA. 2023;330:1127.
     PubMed    
     
     
     
171. RUBIN R
     Updated COVID-19 Vaccine Now Available in US, Recommended for Everyone Older Than 6 Months.
     JAMA. 2023 Sep 18. doi: 10.1001/jama.2023.19759.
     PubMed    
     
     
     
172. TARTOF SY, Frankland TB, Slezak JM, Puzniak L, et al
     Receipt of BNT162b2 Vaccine and COVID-19 Ambulatory Visits in US Children Younger Than 5 Years.
     JAMA. 2023 Sep 15. doi: 10.1001/jama.2023.17473.
     PubMed    
     
     
     
173. DEL RIO C, Malani PN
     COVID-19 in the Fall of 2023-Forgotten but Not Gone.
     JAMA. 2023 Sep 12. doi: 10.1001/jama.2023.19049.
     PubMed    
     
     
     
174. HARRIS E
     Two New Analyses Add to Long COVID Understanding.
     JAMA. 2023;330:905-906.
     PubMed    
     
     
     
175. LUGAR M, Eugster A, Achenbach P, von dem Berge T, et al
     SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood.
     JAMA. 2023 Sep 8. doi: 10.1001/jama.2023.16348.
     PubMed     Abstract available
     
     
     
176. HARRIS E
     High Blood Pressure More Likely After COVID-19 Than Flu.
     JAMA. 2023 Sep 6. doi: 10.1001/jama.2023.16676.
     PubMed    
     
     
     
177. HARRIS E
     HHS To Invest $1.4 Billion in New COVID-19 Vaccines, Therapies.
     JAMA. 2023 Sep 6. doi: 10.1001/jama.2023.16678.
     PubMed    
     
     
     
178. HARRIS E
     Federal Government Announces Long COVID Trials, Research Office.
     JAMA. 2023;330:797.
     PubMed    
     
     
     
179. KENTISH-BARNES N, Resche-Rigon M, Lafarge A, Souppart V, et al
     PTSD Symptoms Among Family Members of Patients With ARDS Caused by COVID-19 After 12 Months.
     JAMA. 2023 Sep 1. doi: 10.1001/jama.2023.15879.
     PubMed    
     
     
     August 2023
180. HARRIS E
     Severe COVID-19 Linked to Enduring Immune System Changes.
     JAMA. 2023 Aug 30. doi: 10.1001/jama.2023.16109.
     PubMed    
     
     
     
181. HARRIS E
     CDC Assesses Risk From BA.2.86, Highly Mutated COVID-19 Variant.
     JAMA. 2023 Aug 30. doi: 10.1001/jama.2023.16105.
     PubMed    
     
     
     
182. HARRIS E
     Lung Transplants for COVID-19 Similarly Successful.
     JAMA. 2023 Aug 23. doi: 10.1001/jama.2023.15450.
     PubMed    
     
     
     
183. YOO SGK, Chung GS, Bahendeka SK, Sibai AM, et al
     Aspirin for Secondary Prevention of Cardiovascular Disease in 51 Low-, Middle-, and High-Income Countries.
     JAMA. 2023;330:715-724.
     PubMed     Abstract available
     
     
     
184. ABBASI J
     What to Know About EG.5, the Latest SARS-CoV-2 "Variant of Interest".
     JAMA. 2023 Aug 18. doi: 10.1001/jama.2023.16498.
     PubMed    
     
     
     
185. RAGLOW Z, Malani PN, Petty LA
     Outpatient Treatment for COVID-19.
     JAMA. 2023 Aug 16. doi: 10.1001/jama.2023.16666.
     PubMed    
     
     
     
186. RUBIN R
     Why Blood Type Seems to Be Linked With COVID-19 Risk.
     JAMA. 2023 Aug 16. doi: 10.1001/jama.2023.15996.
     PubMed    
     
     
     
187. DOS SANTOS RAS, Taccone FS, Annoni F
     Renin-Angiotensin System Modulation in Adults With COVID-19.
     JAMA. 2023;330:663-664.
     PubMed    
     
     
     
188. SELF WH, DeClercq J, Orr M
     Renin-Angiotensin System Modulation in Adults With COVID-19-Reply.
     JAMA. 2023;330:664-665.
     PubMed    
     
     
     
189. HARRIS E
     Case of Middle East Respiratory Syndrome Coronavirus Confirmed.
     JAMA. 2023 Aug 2. doi: 10.1001/jama.2023.13618.
     PubMed    
     
     
     
190. ABBASI J
     A Genetic Explanation for Why Some People Had Asymptomatic COVID-19.
     JAMA. 2023 Aug 2. doi: 10.1001/jama.2023.14703.
     PubMed    
     
     
     
191. DAVIDSON BL, Levi MM
     Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19.
     JAMA. 2023;330:471-472.
     PubMed    
     
     
     
192. GOLIGHER EC, Lawler PR, Zarychanski R
     Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19-Reply.
     JAMA. 2023;330:472-473.
     PubMed    
     
     
     July 2023
193. SURAN M
     HHS Urges Primary Care Clinicians to Help Patients Manage Long COVID's Mental Health Symptoms.
     JAMA. 2023 Jul 26. doi: 10.1001/jama.2023.13605.
     PubMed    
     
     
     
194. HARRIS E
     Free COVID-19 Vaccinations on the Way for Uninsured Adults.
     JAMA. 2023 Jul 26. doi: 10.1001/jama.2023.13133.
     PubMed    
     
     
     
195. GLEASON JL, Tamburro R, Signore C
     Promoting Data Harmonization of COVID-19 Research in Pregnant and Pediatric Populations.
     JAMA. 2023 Jul 20. doi: 10.1001/jama.2023.10835.
     PubMed    
     
     
     
196. MCGARRY BE, Sommers BD, Wilcock AD, Grabowski DC, et al
     Monoclonal Antibody and Oral Antiviral Treatment of SARS-CoV-2 Infection in US Nursing Homes.
     JAMA. 2023 Jul 14:e2312945. doi: 10.1001/jama.2023.12945.
     PubMed    
     
     
     
197. O'HALLORAN JA, Ko ER, Anstrom KJ, Kedar E, et al
     Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.
     JAMA. 2023 Jul 10:e2311043. doi: 10.1001/jama.2023.11043.
     PubMed     Abstract available
     
     
     
198. RUBIN R
     This Fall's COVID-19 Vaccines Will Target Omicron XBB Subvariants, but Who Needs Them Remains to Be Seen.
     JAMA. 2023 Jul 5. doi: 10.1001/jama.2023.10053.
     PubMed    
     
     
     June 2023
199. HARRIS E
     Patients With COVID-19 and Fungal Infections Had High Mortality Rates.
     JAMA. 2023 Jun 28. doi: 10.1001/jama.2023.11957.
     PubMed    
     
     
     
200. MICHAELS D, Wagner GR, Ryan L
     Lessons From COVID-19 for Protecting Workers in the Next Pandemic.
     JAMA. 2023 Jun 16. doi: 10.1001/jama.2023.8229.
     PubMed    
     
     
     
201. ANDREWS N, Stowe J, Miller E, Ramsay M, et al
     BA.1 Bivalent COVID-19 Vaccine Use and Stroke in England.
     JAMA. 2023 Jun 15. doi: 10.1001/jama.2023.10123.
     PubMed    
     
     
     
202. HARRIS E
     Hybrid COVID-19 Immunity Common by Fall of 2022.
     JAMA. 2023 Jun 14. doi: 10.1001/jama.2023.10399.
     PubMed    
     
     
     
203. LANDON E
     An Apple a Day.
     JAMA. 2023 Jun 8. doi: 10.1001/jama.2023.8957.
     PubMed    
     
     
     
204. HARRIS E
     FDA Grants Full Approval to Paxlovid, COVID-19 Antiviral Treatment.
     JAMA. 2023 Jun 7. doi: 10.1001/jama.2023.9925.
     PubMed    
     
     
     
205. DAHNE J, Hawk LW Jr
     Health Equity and Decentralized Trials.
     JAMA. 2023 Jun 1. doi: 10.1001/jama.2023.6982.
     PubMed    
     
     
     May 2023
206. GROSS R, Lo Re V 3rd
     Disentangling the Postacute Sequelae of SARS-CoV-2: E Unibus Pluram (From One, Many).
     JAMA. 2023 May 25. doi: 10.1001/jama.2023.8961.
     PubMed    
     
     
     
207. THAWEETHAI T, Jolley SE, Karlson EW, Levitan EB, et al
     Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection.
     JAMA. 2023 May 25:e238823. doi: 10.1001/jama.2023.8823.
     PubMed     Abstract available
     
     
     
208. HARRIS E
     CDC Updates COVID-19 Data Reporting as US Public Health Emergency Ends.
     JAMA. 2023 May 24. doi: 10.1001/jama.2023.9150.
     PubMed    
     
     
     
209. WEISS A, Donnachie E, Beyerlein A, Ziegler AG, et al
     Type 1 Diabetes Incidence and Risk in Children With a Diagnosis of COVID-19.
     JAMA. 2023 May 22:e238674. doi: 10.1001/jama.2023.8674.
     PubMed    
     
     
     
210. HARRIS E
     WHO Declares End of COVID-19 Global Health Emergency.
     JAMA. 2023 May 17. doi: 10.1001/jama.2023.8656.
     PubMed    
     
     
     
211. HARRIS E
     COVID-19 Vaccine and Health Care Visits for Menstrual Changes.
     JAMA. 2023 May 17. doi: 10.1001/jama.2023.8658.
     PubMed    
     
     
     
212. ASHRAF S, Ashraf N
     Fluvoxamine vs Placebo and Time to Recovery in Outpatients With Mild to Moderate COVID-19.
     JAMA. 2023;329:1702.
     PubMed    
     
     
     
213. MCCARTHY MW, Lindsell CJ, Naggie S
     Fluvoxamine vs Placebo and Time to Recovery in Outpatients With Mild to Moderate COVID-19-Reply.
     JAMA. 2023;329:1702-1703.
     PubMed    
     
     
     
214. MARCUS R
     New Alzheimer Disease Drugs, Long COVID and the Central Nervous System, and a Nasal Spray for Migraines-Highlights From the 2023 American Academy of Neurology Conference.
     JAMA. 2023 May 10. doi: 10.1001/jama.2023.4389.
     PubMed    
     
     
     
215. HARRIS E
     BCG Vaccine Not Effective Against COVID-19.
     JAMA. 2023 May 3. doi: 10.1001/jama.2023.7763.
     PubMed    
     
     
     
216. HARRIS E
     XBB.1.16 Deemed COVID-19 "Variant of Interest".
     JAMA. 2023 May 3. doi: 10.1001/jama.2023.7768.
     PubMed    
     
     
     
217. LANDHUIS EW
     How Primary Care Physicians Can Recognize and Treat Long COVID.
     JAMA. 2023 May 3. doi: 10.1001/jama.2023.6604.
     PubMed    
     
     
     
218. BOHRMANN B, Massa MS, Ross S, Lewington S, et al
     Body Mass Index and Risk of Hospitalization or Death Due to Lower or Upper Respiratory Tract Infection.
     JAMA. 2023;329:1512-1514.
     PubMed    
     
     
     
219. BOMMERSBACH TJ, McKean AJ, Olfson M, Rhee TG, et al
     National Trends in Mental Health-Related Emergency Department Visits Among Youth, 2011-2020.
     JAMA. 2023;329:1469-1477.
     PubMed     Abstract available
     
     
     April 2023
220. HARRIS E
     FDA Simplifies COVID-19 Vaccination, Permits Some Additional Doses.
     JAMA. 2023 Apr 26. doi: 10.1001/jama.2023.6624.
     PubMed    
     
     
     
221. HARRIS E
     How Parents' Views Are Tied to Children's COVID-19 Vaccination.
     JAMA. 2023 Apr 19. doi: 10.1001/jama.2023.6292.
     PubMed    
     
     
     
222. SPUNGEN H, Burton J, Schenkel S, Schriger DL, et al
     Completeness and Spin of medRxiv Preprint and Associated Published Abstracts of COVID-19 Randomized Clinical Trials.
     JAMA. 2023;329:1310-1312.
     PubMed    
     
     
     
223. HARRIS E
     Updated WHO Guidance for Prioritizing COVID-19 Vaccines.
     JAMA. 2023 Apr 12. doi: 10.1001/jama.2023.6256.
     PubMed    
     
     
     
224. LEE MMY, McMurray JJV
     Lack of Benefit of Renin-Angiotensin System Inhibitors in COVID-19.
     JAMA. 2023;329:1155-1156.
     PubMed    
     
     
     
225. SELF WH, Shotwell MS, Gibbs KW, de Wit M, et al
     Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials.
     JAMA. 2023;329:1170-1182.
     PubMed     Abstract available
     
     
     
226. LAWLER PR, Derde LPG, van de Veerdonk FL, McVerry BJ, et al
     Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.
     JAMA. 2023;329:1183-1196.
     PubMed     Abstract available
     
     
     
227. XIE Y, Choi T, Al-Aly Z
     Risk of Death in Patients Hospitalized for COVID-19 vs Seasonal Influenza in Fall-Winter 2022-2023.
     JAMA. 2023 Apr 6. doi: 10.1001/jama.2023.5348.
     PubMed    
     
     
     
228. HARRIS E
     Study: US COVID-19 Outcomes Tied to State Characteristics and Policies.
     JAMA. 2023 Apr 5. doi: 10.1001/jama.2023.5622.
     PubMed    
     
     
     
229. AMMIRATI E, Moslehi JJ
     Diagnosis and Treatment of Acute Myocarditis: A Review.
     JAMA. 2023;329:1098-1113.
     PubMed     Abstract available
     
     
     
230. HARRIS E
     Public Had Most Trust in Advice From Physicians, Nurses During Pandemic.
     JAMA. 2023;329:1053.
     PubMed    
     
     
     
231. HARRIS E
     "Living" Systematic Review of Mental Health During Pandemic.
     JAMA. 2023;329:1054.
     PubMed    
     
     
     
232. ESMAIL LC, Kapp P, Assi R, Wood J, et al
     Sharing of Individual Patient-Level Data by Trialists of Randomized Clinical Trials of Pharmacological Treatments for COVID-19.
     JAMA. 2023 Apr 3:e234590. doi: 10.1001/jama.2023.4590.
     PubMed    
     
     
     March 2023
233. HARRIS E
     Cold Virus Provided Cross-reactivity Against SARS-CoV-2 in Children.
     JAMA. 2023 Mar 29. doi: 10.1001/jama.2023.5261.
     PubMed    
     
     
     
234. CAMPO R
     Illness Metaphors and COVID-19.
     JAMA. 2023;329:1035.
     PubMed    
     
     
     
235. HARRIS E
     Nasally Administered Monoclonal Antibody for COVID-19.
     JAMA. 2023 Mar 22. doi: 10.1001/jama.2023.4000.
     PubMed    
     
     
     
236. GOLIGHER EC, Lawler PR, Jensen TP, Talisa V, et al
     Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19.
     JAMA. 2023 Mar 21. doi: 10.1001/jama.2023.3651.
     PubMed     Abstract available
     
     
     
237. LONDON AJ, Seymour CW
     The Ethics of Clinical Research: Managing Persistent Uncertainty.
     JAMA. 2023;329:884-885.
     PubMed    
     
     
     
238. COKER TR, Cheng TL, Ybarra M
     Addressing the Long-term Effects of the COVID-19 Pandemic on Children and Families: A Report From the National Academies of Sciences, Engineering, and Medicine.
     JAMA. 2023 Mar 16. doi: 10.1001/jama.2023.4371.
     PubMed    
     
     
     
239. HARRIS E
     FDA Approves First Over-the-counter Combined COVID-19 and Flu Test.
     JAMA. 2023 Mar 8. doi: 10.1001/jama.2023.3192.
     PubMed    
     
     
     
240. SURAN M
     Long COVID Linked With Unemployment in New Analysis.
     JAMA. 2023;329:701-702.
     PubMed    
     
     
     
241. RUBIN R
     Highlights From CROI, the Conference on Retroviruses and Opportunistic Infections-Postexposure Prophylaxis for Sexually Transmitted Infections, a New Protease Inhibitor for COVID-19, Goals for Preventing HIV Transmission, and More.
     JAMA. 2023 Mar 1. doi: 10.1001/jama.2023.0158.
     PubMed    
     
     
     
242. HARRIS E
     Meta-analysis: COVID-19 Infection Protects Against Severe Disease.
     JAMA. 2023 Mar 1. doi: 10.1001/jama.2023.2885.
     PubMed    
     
     
     
243. HARRIS E
     Prior COVID-19 Infection Tied to Lasting Lung Abnormalities.
     JAMA. 2023 Mar 1. doi: 10.1001/jama.2023.2886.
     PubMed    
     
     
     February 2023
244. NEPRASH HT, Golberstein E, Ganguli I, Chernew ME, et al
     Association of Evaluation and Management Payment Policy Changes With Medicare Payment to Physicians by Specialty.
     JAMA. 2023;329:662-669.
     PubMed     Abstract available
     
     
     
245. HARRIS E
     Study: No New SARS-CoV-2 Variants in Recent Outbreak in China.
     JAMA. 2023 Feb 22. doi: 10.1001/jama.2023.2089.
     PubMed    
     
     
     
246. HARRIS E
     COVID-19 Vaccination During Pregnancy Protected Infants.
     JAMA. 2023 Feb 22. doi: 10.1001/jama.2023.2098.
     PubMed    
     
     
     
247. LARKIN H
     National Academies: Expand US Wastewater Disease Surveillance.
     JAMA. 2023;329:531.
     PubMed    
     
     
     
248. NAGGIE S, Boulware DR, Lindsell CJ, Stewart TG, et al
     Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial.
     JAMA. 2023 Feb 20:e231650. doi: 10.1001/jama.2023.1650.
     PubMed     Abstract available
     
     
     
249. BIBBINS-DOMINGO K, Malani PN
     At a Higher Dose and Longer Duration, Ivermectin Still Not Effective Against COVID-19.
     JAMA. 2023 Feb 20. doi: 10.1001/jama.2023.1922.
     PubMed    
     
     
     
250. HARRIS E
     NIH Considers Lessons Learned During COVID-19 Pandemic.
     JAMA. 2023 Feb 15. doi: 10.1001/jama.2023.1553.
     PubMed    
     
     
     
251. HARRIS E
     Most COVID-19 Deaths Worldwide Were Among Older People.
     JAMA. 2023 Feb 15. doi: 10.1001/jama.2023.1554.
     PubMed    
     
     
     
252. RUBIN R
     Questions Remain About What SARS-CoV-2 Variants Should Go Into the Annual COVID-19 Vaccines Proposed by the FDA.
     JAMA. 2023 Feb 15. doi: 10.1001/jama.2022.22285.
     PubMed    
     
     
     
253. CHANG R
     SARS-CoV-2 Infection and Presymptomatic Type 1 Diabetes Autoimmunity in Children and Adolescents.
     JAMA. 2023;329:512.
     PubMed    
     
     
     
254. REWERS M, Ziegler AG
     SARS-CoV-2 Infections and Presymptomatic Type 1 Diabetes Autoimmunity in Children and Adolescents-Reply.
     JAMA. 2023;329:512-513.
     PubMed    
     
     
     
255. HARRIS E
     Updated COVID-19 Guidance for People Who Are Immunocompromised.
     JAMA. 2023 Feb 8. doi: 10.1001/jama.2023.1176.
     PubMed    
     
     
     
256. HONG KH, Sung H
     SARS-CoV-2 Results in Self-collected Nasal Swabs vs Swabs Collected by Health Care Workers in Children and Adolescents.
     JAMA. 2023;329:424-425.
     PubMed    
     
     
     
257. CHU WM, Wang CY, Wei JC
     Vaccination, Acute Myocardial Infarction, and Ischemic Stroke After COVID-19 Infection.
     JAMA. 2023;329:426.
     PubMed    
     
     
     
258. WAGGONER JJ, Tyburski EA, Lam WA
     SARS-CoV-2 Results in Self-collected Nasal Swabs vs Swabs Collected by Health Care Workers in Children and Adolescents-Reply.
     JAMA. 2023;329:425-426.
     PubMed    
     
     
     
259. HUH K, Kim YE, Jung J
     Vaccination, Acute Myocardial Infarction, and Ischemic Stroke After COVID-19 Infection-Reply.
     JAMA. 2023;329:426-427.
     PubMed    
     
     
     
260. LARKIN H
     Newly Discovered Host-Cell Factor Could Be a COVID-19 Treatment Target.
     JAMA. 2023 Feb 1. doi: 10.1001/jama.2023.0748.
     PubMed    
     
     
     
261. LARKIN H
     High COVID-19 Rates Prompt Call for Better Nursing Home Protections.
     JAMA. 2023 Feb 1. doi: 10.1001/jama.2023.0740.
     PubMed    
     
     
     
262. LARKIN H
     Hybrid Immunity More Protective Than Prior SARS-CoV-2 Infection Alone.
     JAMA. 2023 Feb 1. doi: 10.1001/jama.2023.0743.
     PubMed    
     
     
     January 2023
263. ROLFES MA, Talbot HK, McLean HQ, Stockwell MS, et al
     Household Transmission of Influenza A Viruses in 2021-2022.
     JAMA. 2023 Jan 26. doi: 10.1001/jama.2023.0064.
     PubMed     Abstract available
     
     
     
264. HARRIS E
     NIH Funds Research on Severe COVID-19-Related Illness in Children.
     JAMA. 2023 Jan 25. doi: 10.1001/jama.2023.0391.
     PubMed    
     
     
     
265. RUBIN R
     Large Cohort Study Finds Possible Association Between Postural Orthostatic Tachycardia Syndrome and COVID-19 Vaccination but Far Stronger Link With SARS-CoV-2 Infection.
     JAMA. 2023 Jan 25. doi: 10.1001/jama.2023.0050.
     PubMed    
     
     
     
266. LARKIN HD
     Patients With Mild COVID-19 at Risk of Some Post-COVID-19 Condition Symptoms.
     JAMA. 2023 Jan 18. doi: 10.1001/jama.2022.24498.
     PubMed    
     
     
     
267. LARKIN HD
     NIH Pilots Telehealth Program for COVID-19.
     JAMA. 2023 Jan 18. doi: 10.1001/jama.2022.24494.
     PubMed    
     
     
     
268. BHIMRAJ A, Gallagher JC
     Lack of Benefit of Fluvoxamine for COVID-19.
     JAMA. 2023 Jan 12. doi: 10.1001/jama.2022.23954.
     PubMed    
     
     
     
269. MCCARTHY MW, Naggie S, Boulware DR, Lindsell CJ, et al
     Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
     JAMA. 2023 Jan 12. doi: 10.1001/jama.2022.24100.
     PubMed     Abstract available
     
     
     
270. RUBIN R
     Swab the Throat as Well as the Nose? The Debate Over the Best Way to Test for SARS-CoV-2.
     JAMA. 2023 Jan 11. doi: 10.1001/jama.2022.23311.
     PubMed    
     
     
     
271. HOLMGREN AJ, Byron ME, Grouse CK, Adler-Milstein J, et al
     Association Between Billing Patient Portal Messages as e-Visits and Patient Messaging Volume.
     JAMA. 2023 Jan 6. doi: 10.1001/jama.2022.24710.
     PubMed    
     
     
     
272. LARKIN H
     Combined COVID-19 and Flu Test Authorized for Point-of-Care Use.
     JAMA. 2023;329:14-15.
     PubMed    
     
     
     December 2022
273. SURAN M
     VA Finds Nirmatrelvir Associated With Lower Risk of Long COVID.
     JAMA. 2022;328:2386.
     PubMed    
     
     
     
274. SURAN M
     HHS Releases New Report on Long COVID Experiences.
     JAMA. 2022;328:2386.
     PubMed    
     
     
     
275. YII CY, Yong SB, Wei JC
     COVID-19 vs Influenza for Risk of Thrombotic Events in Hospitalized Patients.
     JAMA. 2022;328:2457-2458.
     PubMed    
     
     
     
276. LO RE V 3RD, Dutcher SK, Cocoros NM
     COVID-19 vs Influenza for Risk of Thrombotic Events in Hospitalized Patients-Reply.
     JAMA. 2022;328:2458-2459.
     PubMed    
     
     
     
277. SLOMSKI A
     Angiotensin Receptor Blockers Not Effective Against COVID-19.
     JAMA. 2022;328:2387.
     PubMed    
     
     
     
278. SLOMSKI A
     Moderna COVID-19 Vaccine Safe and Effective for Children 6 Months to 5 Years.
     JAMA. 2022;328:2388.
     PubMed    
     
     
     
279. MANGURIAN C
     Getting Treated for COVID-19 Shouldn't Be This Difficult.
     JAMA. 2022 Dec 22. doi: 10.1001/jama.2022.23155.
     PubMed    
     
     
     
280. LARKIN H
     Dogs May Reliably Detect SARS-CoV-2 Infections at Mass Events.
     JAMA. 2022;328:2294.
     PubMed    
     
     
     
281. LARKIN H
     How Early COVID-19 Restrictions Effected Progress on Neglected Tropical Diseases.
     JAMA. 2022;328:2294-2295.
     PubMed    
     
     
     
282. BARNETT ML, Sax PE
     Long-term Follow-up After Critical COVID-19: REMAP-CAP Revisited.
     JAMA. 2022 Dec 16. doi: 10.1001/jama.2022.23700.
     PubMed    
     
     
     
283. HIGGINS AM, Berry LR, Lorenzi E, Murthy S, et al
     Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.
     JAMA. 2022 Dec 16. doi: 10.1001/jama.2022.23257.
     PubMed     Abstract available
     
     
     
284. ABBASI J
     Amid Ohio Measles Outbreak, New Global Report Warns of Decreased Vaccination During COVID-19 Pandemic.
     JAMA. 2022 Dec 15. doi: 10.1001/jama.2022.23241.
     PubMed    
     
     
     
285. MARKS PW, Gruppuso PA, Adashi EY
     Urgent Need for Next-Generation COVID-19 Vaccines.
     JAMA. 2022 Dec 9. doi: 10.1001/jama.2022.22759.
     PubMed    
     
     
     
286. LARKIN HD
     Novavax COVID-19 Vaccine Booster Authorized.
     JAMA. 2022;328:2101.
     PubMed    
     
     
     
287. BRUZELIUS E, Martins SS
     US Trends in Drug Overdose Mortality Among Pregnant and Postpartum Persons, 2017-2020.
     JAMA. 2022;328:2159-2161.
     PubMed    
     
     
     
288. BUENO DE MESQUITA PJ, Sokas R
     SARS-CoV-2 Reduction in Shared Indoor Air.
     JAMA. 2022;328:2163.
     PubMed    
     
     
     
289. SRIKRISHNA D, Karan A, Dhillon RS
     SARS-CoV-2 Reduction in Shared Indoor Air.
     JAMA. 2022;328:2162-2163.
     PubMed    
     
     
     
290. MANMADHAN A, Ahuja T
     Association Between COVID-19 Booster Vaccination and Omicron Infection in a Cohort of Players and Staff in the National Basketball Association.
     JAMA. 2022;328:2164-2165.
     PubMed    
     
     
     
291. DOWELL D, Lindsley WG, Brooks JT
     SARS-CoV-2 Reduction in Shared Indoor Air-Reply.
     JAMA. 2022;328:2163-2164.
     PubMed    
     
     
     
292. MACK CD, Anderson DJ, DiFiori J
     Association Between COVID-19 Booster Vaccination and Omicron Infection in a Cohort of Players and Staff in the National Basketball Association-Reply.
     JAMA. 2022;328:2165.
     PubMed    
     
     
     
293. GANDHI RT, Bedimo R, Hoy JF, Landovitz RJ, et al
     Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel.
     JAMA. 2022 Dec 1. doi: 10.1001/jama.2022.22246.
     PubMed     Abstract available
     
     
     November 2022
294. ABBASI J
     Highlights From the American Heart Association's Scientific Sessions 2022-COVID-19's Ripple Effects, a Triglyceride Disappointment, Gene Editing Advances, and More.
     JAMA. 2022 Nov 23. doi: 10.1001/jama.2022.17757.
     PubMed    
     
     
     
295. SLOMSKI A
     Intranasal COVID-19 Vaccine Disappointing in First-in-Human Trial.
     JAMA. 2022;328:2003.
     PubMed    
     
     
     
296. BILINSKI A, Thompson K, Emanuel E
     COVID-19 and Excess All-Cause Mortality in the US and 20 Comparison Countries, June 2021-March 2022.
     JAMA. 2022 Nov 18. pii: 2798990. doi: 10.1001/jama.2022.21795.
     PubMed    
     
     
     
297. RUBIN R
     How Immune-Evasive Omicron Offspring and a Lack of Mitigation Measures Could Shape a COVID-19 Winter Wave.
     JAMA. 2022 Nov 16. pii: 2798913. doi: 10.1001/jama.2022.17758.
     PubMed    
     
     
     
298. YEK C, Kadri SS
     Massachusetts Data on Excess Mortality During the Delta and Omicron Waves of COVID-19.
     JAMA. 2022;328:1977.
     PubMed    
     
     
     
299. FAUST JS, Renton B, Du C
     Massachusetts Data on Excess Mortality During the Delta and Omicron Waves of COVID-19.
     JAMA. 2022;328:1977-1978.
     PubMed    
     
     
     
300. LARKIN HD
     COVID-19 Limited Access to Sexual and Reproductive Health Services.
     JAMA. 2022;328:1896-1897.
     PubMed    
     
     
     
301. SURAN M
     Highlights From Infectious Disease Week 2022-COVID-19, HIV, Monkeypox, and Polio.
     JAMA. 2022 Nov 9. pii: 2798547. doi: 10.1001/jama.2022.17754.
     PubMed    
     
     
     
302. KUEHN BM
     Second COVID-19 Booster Increases Protection for Nursing Home Patients.
     JAMA. 2022;328:1800-1801.
     PubMed    
     
     
     October 2022
303. BERNARD SA, Bray JE, Smith K, Stephenson M, et al
     Effect of Lower vs Higher Oxygen Saturation Targets on Survival to Hospital Discharge Among Patients Resuscitated After Out-of-Hospital Cardiac Arrest: The EXACT Randomized Clinical Trial.
     JAMA. 2022 Oct 26. pii: 2798013. doi: 10.1001/jama.2022.17701.
     PubMed     Abstract available
     
     
     
304. SURAN M
     VA Guidebook on Long COVID.
     JAMA. 2022;328:1580.
     PubMed    
     
     
     
305. SLOMSKI A
     Vitamin D Supplements Don't Reduce COVID-19 Risk.
     JAMA. 2022;328:1581.
     PubMed    
     
     
     
306. WALKER MD, Shane E
     Hypercalcemia: A Review.
     JAMA. 2022;328:1624-1636.
     PubMed     Abstract available
     
     
     
307. FRIEDEN TR, McClelland A
     Preparing for Pandemics and Other Health Threats: Societal Approaches to Protect and Improve Health.
     JAMA. 2022;328:1585-1586.
     PubMed    
     
     
     
308. EISENBERG MD, Eddelbuettel JCP, McGinty EE
     Employment in Office-Based and Intensive Behavioral Health Settings in the US, 2016-2021.
     JAMA. 2022;328:1642-1643.
     PubMed    
     
     
     
309. NAGGIE S, Boulware DR, Lindsell CJ, Stewart TG, et al
     Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
     JAMA. 2022 Oct 21. pii: 2797483. doi: 10.1001/jama.2022.18590.
     PubMed     Abstract available
     
     
     
310. JIANG Q, Zhang YF, Hu P
     Multisystem Inflammatory Syndrome in Children During 3 SARS-CoV-2 Pandemic Waves in Israel.
     JAMA. 2022;328:1561-1562.
     PubMed    
     
     
     
311. SHAVIT I, Koppel JH, Levy N
     Multisystem Inflammatory Syndrome in Children During 3 SARS-CoV-2 Pandemic Waves in Israel-Reply.
     JAMA. 2022;328:1562.
     PubMed    
     
     
     
312. THOMPSON MG, Yoon SK, Naleway AL, Meece J, et al
     Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers.
     JAMA. 2022;328:1523-1533.
     PubMed     Abstract available
     
     
     
313. BELLANDI D
     Estimate: 10.5 Million Children Lost a Parent, Caregiver to COVID-19.
     JAMA. 2022;328:1490.
     PubMed    
     
     
     
314. HSU CK, Lai CC
     Risk of Infection and Hospitalization Among Children and Adolescents in New York After Emergence of the SARS-CoV-2 Omicron Variant.
     JAMA. 2022;328:1460.
     PubMed    
     
     
     
315. DORABAWILA V, Bassett MT, Rosenberg ES
     Risk of Infection and Hospitalization Among Children and Adolescents in New York After Emergence of the SARS-CoV-2 Omicron Variant-Reply.
     JAMA. 2022;328:1460-1461.
     PubMed    
     
     
     
316. KUEHN BM
     Lowest US Life Expectancy Since 1996 Linked to COVID-19.
     JAMA. 2022;328:1389.
     PubMed    
     
     
     
317. WULF HANSON S, Abbafati C, Aerts JG, Al-Aly Z, et al
     Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021.
     JAMA. 2022 Oct 10. pii: 2797443. doi: 10.1001/jama.2022.18931.
     PubMed     Abstract available
     
     
     
318. ABBASI J
     White House Advisor Nahid Bhadelia, MD, MALD, on COVID-19 in Resource-Limited Nations-Undercounted Deaths, Vaccine Inequity, and More.
     JAMA. 2022 Oct 5. pii: 2797281. doi: 10.1001/jama.2022.13663.
     PubMed    
     
     
     
319. SLOMSKI A
     Long COVID in Children.
     JAMA. 2022;328:1288.
     PubMed    
     
     
     
320. GERSHENGORN HB
     Effect of Awake Prone Positioning on Patients With COVID-19 and Acute Respiratory Failure.
     JAMA. 2022;328:1353-1354.
     PubMed    
     
     
     
321. RAGHUNATHAN K, Raghunathan A
     Effect of Awake Prone Positioning on Patients With COVID-19 and Acute Respiratory Failure.
     JAMA. 2022;328:1354.
     PubMed    
     
     
     
322. ALHAZZANI W, Weatherald J, Arabi YM
     Effect of Awake Prone Positioning on Patients With COVID-19 and Acute Respiratory Failure-Reply.
     JAMA. 2022;328:1354-1355.
     PubMed    
     
     
     September 2022
323. GARDNER L
     The COVID-19 Dashboard for Real-time Tracking of the Pandemic: The Lasker-Bloomberg Public Service Award.
     JAMA. 2022 Sep 28. pii: 2796722. doi: 10.1001/jama.2022.15590.
     PubMed    
     
     
     
324. NICHOL AD, O'Kane C, McAuley DF
     Respiratory Support in the Time of COVID-19.
     JAMA. 2022;328:1203-1205.
     PubMed    
     
     
     
325. SLOMSKI A
     Repurposed Drugs Failed to Prevent Severe COVID-19.
     JAMA. 2022;328:1171.
     PubMed    
     
     
     
326. FRAT JP, Quenot JP, Badie J, Coudroy R, et al
     Effect of High-Flow Nasal Cannula Oxygen vs Standard Oxygen Therapy on Mortality in Patients With Respiratory Failure Due to COVID-19: The SOHO-COVID Randomized Clinical Trial.
     JAMA. 2022;328:1212-1222.
     PubMed     Abstract available
     
     
     
327. KUEHN BM
     Bus and Urban Transit Workers Have Highest COVID-19 Risk.
     JAMA. 2022;328:1173.
     PubMed    
     
     
     
328. KELLY JD, Leonard S, Hoggatt KJ, Boscardin WJ, et al
     Incidence of Severe COVID-19 Illness Following Vaccination and Booster With BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines.
     JAMA. 2022 Sep 26. pii: 2796892. doi: 10.1001/jama.2022.17985.
     PubMed     Abstract available
     
     
     
329. TENFORDE MW, Link-Gelles R, Patel MM
     Long-term Protection Associated With COVID-19 Vaccination and Prior Infection.
     JAMA. 2022 Sep 26. pii: 2796894. doi: 10.1001/jama.2022.14660.
     PubMed    
     
     
     
330. LIN DY, Gu Y, Xu Y, Wheeler B, et al
     Association of Primary and Booster Vaccination and Prior Infection With SARS-CoV-2 Infection and Severe COVID-19 Outcomes.
     JAMA. 2022 Sep 26. pii: 2796893. doi: 10.1001/jama.2022.17876.
     PubMed     Abstract available
     
     
     
331. RIDGWAY JP, Tideman S, French T, Wright B, et al
     Odds of Hospitalization for COVID-19 After 3 vs 2 Doses of mRNA COVID-19 Vaccine by Time Since Booster Dose.
     JAMA. 2022 Sep 23. pii: 2796847. doi: 10.1001/jama.2022.17811.
     PubMed    
     
     
     
332. RUBIN R
     The Dreaded "Twindemic" of Influenza and COVID-19 Has Not Yet Materialized-Might This Be the Year?
     JAMA. 2022 Sep 21. pii: 2796806. doi: 10.1001/jama.2022.15062.
     PubMed    
     
     
     
333. ARABI YM, Aldekhyl S, Al Qahtani S, Al-Dorzi HM, et al
     Effect of Helmet Noninvasive Ventilation vs Usual Respiratory Support on Mortality Among Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19: The HELMET-COVID Randomized Clinical Trial.
     JAMA. 2022;328:1063-1072.
     PubMed     Abstract available
     
     
     
334. LARKIN HD
     COVID-19 Health Policies and Economies in Nordic Countries.
     JAMA. 2022;328:1029.
     PubMed    
     
     
     
335. MATTA S, Nicholas LH
     Changes in Unemployment Among Health Care Workers Following the COVID-19 Pandemic.
     JAMA. 2022 Sep 19. pii: 2796661. doi: 10.1001/jama.2022.17608.
     PubMed    
     
     
     
336. LARKIN HD
     New Data on Heterologous COVID-19 Vaccine Combinations.
     JAMA. 2022;328:916-917.
     PubMed    
     
     
     
337. LARKIN HD
     Antibody Found in Mice Neutralizes SARS-CoV-2 and SARS-CoV-1.
     JAMA. 2022;328:916-917.
     PubMed    
     
     
     
338. KUEHN BM
     CDC Streamlines COVID-19 Guidance.
     JAMA. 2022;328:918-919.
     PubMed    
     
     
     
339. WEBBER C, Myran DT, Milani C, Turcotte L, et al
     Cognitive Decline in Long-term Care Residents Before and During the COVID-19 Pandemic in Ontario, Canada.
     JAMA. 2022 Sep 12. pii: 2796449. doi: 10.1001/jama.2022.17214.
     PubMed    
     
     
     
340. ABBASI J
     The US Now Has a Research Plan for Long COVID-Is It Enough?
     JAMA. 2022;328:812-814.
     PubMed    
     
     
     August 2022
341. BARNETT ML, Waken RJ, Zheng J, Orav EJ, et al
     Changes in Health and Quality of Life in US Skilled Nursing Facilities by COVID-19 Exposure Status in 2020.
     JAMA. 2022 Aug 29. pii: 2795935. doi: 10.1001/jama.2022.15071.
     PubMed     Abstract available
     
     
     
342. YOUNGSTER I
     Self-sampling for SARS-CoV-2 Detection in Children.
     JAMA. 2022 Aug 26. pii: 2795838. doi: 10.1001/jama.2022.15225.
     PubMed    
     
     
     
343. WAGGONER JJ, Vos MB, Tyburski EA, Nguyen PV, et al
     Concordance of SARS-CoV-2 Results in Self-collected Nasal Swabs vs Swabs Collected by Health Care Workers in Children and Adolescents.
     JAMA. 2022 Aug 26. pii: 2795837. doi: 10.1001/jama.2022.14877.
     PubMed     Abstract available
     
     
     
344. SOLIS-MOREIRA J
     Study: New Wastewater Surveillance Method Detected SARS-CoV-2 Variants of Concern Up to 2 Weeks Before Clinical Tests.
     JAMA. 2022 Aug 24. pii: 2795815. doi: 10.1001/jama.2022.12563.
     PubMed    
     
     
     
345. RUBIN R
     Despite Its Fan Base, Newly Authorized "Traditional" Novavax COVID-19 Vaccine Is Having Trouble Gaining a Foothold in the US.
     JAMA. 2022 Aug 24. pii: 2795814. doi: 10.1001/jama.2022.13661.
     PubMed    
     
     
     
346. SURAN M
     Free COVID-19 Tests for People With Visual Impairment.
     JAMA. 2022;328:699.
     PubMed    
     
     
     
347. SLOMSKI A
     Antibody Testing's Limits for Detecting Prior SARS-CoV-2 Infection.
     JAMA. 2022;328:700-701.
     PubMed    
     
     
     
348. RUBIN R
     Pharmacists Allowed to Prescribe COVID-19 Antiviral.
     JAMA. 2022;328:612.
     PubMed    
     
     
     
349. LO RE V 3RD, Dutcher SK, Connolly JG, Perez-Vilar S, et al
     Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients.
     JAMA. 2022;328:637-651.
     PubMed     Abstract available
     
     
     
350. LARKIN HD
     Preventing COVID-19, Saving Lives in Lower-Income Countries.
     JAMA. 2022;328:611.
     PubMed    
     
     
     
351. KUEHN BM
     Reduced HIV Testing and Diagnoses During COVID-19 Pandemic.
     JAMA. 2022;328:519.
     PubMed    
     
     
     
352. LARKIN HD
     Evolving Omicron Subvariants Are More Resistant to Antibody Therapy.
     JAMA. 2022;328:518.
     PubMed    
     
     
     
353. REWERS M, Bonifacio E, Ewald D, Geno Rasmussen C, et al
     SARS-CoV-2 Infections and Presymptomatic Type 1 Diabetes Autoimmunity in Children and Adolescents From Colorado, USA, and Bavaria, Germany.
     JAMA. 2022 Aug 5. pii: 2795226. doi: 10.1001/jama.2022.14092.
     PubMed    
     
     
     
354. MADHUSOODANAN J
     Animal Reservoirs-Where the Next SARS-CoV-2 Variant Could Arise.
     JAMA. 2022 Aug 3. pii: 2795140. doi: 10.1001/jama.2022.9789.
     PubMed    
     
     
     
355. LEVINE RL
     Addressing the Long-term Effects of COVID-19.
     JAMA. 2022 Aug 3. pii: 2795139. doi: 10.1001/jama.2022.14089.
     PubMed    
     
     
     
356. SLOMSKI A
     Sickle Cell Trait Associated With Kidney Failure and COVID-19 Death.
     JAMA. 2022;328:415.
     PubMed    
     
     
     
357. SLOMSKI A
     Maternal Death Rate Increased During Early COVID-19 Pandemic.
     JAMA. 2022;328:415.
     PubMed    
     
     
     
358. GENZEN JR, Rychert J, George TI
     Integrity of SARS-CoV-2 Laboratory-Developed Tests.
     JAMA. 2022;328:478.
     PubMed    
     
     
     
359. ADASHI EY, Cohen G
     Integrity of SARS-CoV-2 Laboratory-Developed Tests-Reply.
     JAMA. 2022;328:478-479.
     PubMed    
     
     
     
360. BIRNIE E, Biemond JJ, Appelman B, de Bree GJ, et al
     Development of Resistance-Associated Mutations After Sotrovimab Administration in High-risk Individuals Infected With the SARS-CoV-2 Omicron Variant.
     JAMA. 2022 Aug 1. pii: 2794999. doi: 10.1001/jama.2022.13854.
     PubMed    
     
     
     July 2022
361. VASAN A, Foote M, Long T
     Ensuring Widespread and Equitable Access to Treatments for COVID-19.
     JAMA. 2022 Jul 29. pii: 2794967. doi: 10.1001/jama.2022.13554.
     PubMed    
     
     
     
362. ZENG G
     SARS-CoV-2 Omicron Variant Severity in Ontario, Canada.
     JAMA. 2022;328:395.
     PubMed    
     
     
     
363. ULLOA AC, Buchan SA, Brown KA
     SARS-CoV-2 Omicron Variant Severity in Ontario, Canada-Reply.
     JAMA. 2022;328:395-396.
     PubMed    
     
     
     
364. SLOMSKI A
     Evusheld Reduces COVID-19 Disease Severity Among Unvaccinated Adults.
     JAMA. 2022;328:322.
     PubMed    
     
     
     
365. KUEHN BM
     Persistent Disparities in COVID-19 Antiviral Dispensing.
     JAMA. 2022;328:323.
     PubMed    
     
     
     
366. MALANI AG, Malani AN
     Preventive Medication for COVID-19 Infection.
     JAMA. 2022 Jul 25. pii: 2794799. doi: 10.1001/jama.2022.13214.
     PubMed    
     
     
     
367. KIM YE, Huh K, Park YJ, Peck KR, et al
     Association Between Vaccination and Acute Myocardial Infarction and Ischemic Stroke After COVID-19 Infection.
     JAMA. 2022 Jul 22. pii: 2794753. doi: 10.1001/jama.2022.12992.
     PubMed    
     
     
     
368. WEBER E, Van Buren N, Cunningham T
     COVID-19 ARDS and Posttraumatic Stress Disorder in Family Members After ICU Discharge.
     JAMA. 2022;328:301-302.
     PubMed    
     
     
     
369. LIN HY, Chen MH, Liang CS
     COVID-19 ARDS and Posttraumatic Stress Disorder in Family Members After ICU Discharge.
     JAMA. 2022;328:301.
     PubMed    
     
     
     
370. KENIK J
     Remote Patient Monitoring During COVID-19.
     JAMA. 2022;328:302-303.
     PubMed    
     
     
     
371. AZOULAY E, Pochard F, Kentish-Barnes N
     COVID-19 ARDS and Posttraumatic Stress Disorder in Family Members After ICU Discharge-Reply.
     JAMA. 2022;328:302.
     PubMed    
     
     
     
372. PRONOVOST PJ, Cole MD, Hughes RM
     Remote Patient Monitoring During COVID-19-Reply.
     JAMA. 2022;328:303-304.
     PubMed    
     
     
     
373. LARKIN HD
     Mix-and-Match COVID-19 Boosters After Inactivated Virus Vaccine.
     JAMA. 2022;328:234.
     PubMed    
     
     
     
374. RUBIN R
     COVID-19 Boosters This Fall to Include Omicron Antigen, but Questions Remain About Its Value.
     JAMA. 2022 Jul 8. pii: 2794259. doi: 10.1001/jama.2022.11252.
     PubMed    
     
     
     
375. SCHWANDT H, Currie J, von Wachter T, Kowarski J, et al
     Changes in the Relationship Between Income and Life Expectancy Before and During the COVID-19 Pandemic, California, 2015-2021.
     JAMA. 2022 Jul 7. pii: 2794146. doi: 10.1001/jama.2022.10952.
     PubMed     Abstract available
     
     
     
376. LARKIN HD
     First Nonprescription COVID-19 Test That Also Detects Flu and RSV.
     JAMA. 2022;328:11.
     PubMed    
     
     
     
377. LARKIN HD
     Expiration Dates Extended on COVID-19 Monoclonal Antibody Therapies.
     JAMA. 2022;328:11.
     PubMed    
     
     
     
378. KUEHN BM
     WHO: Pandemic Sparked a Push for Global Mental Health Transformation.
     JAMA. 2022;328:5-7.
     PubMed    
     
     
     
379. AZZOLINI E, Levi R, Sarti R, Pozzi C, et al
     Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers.
     JAMA. 2022 Jul 1. pii: 2794072. doi: 10.1001/jama.2022.11691.
     PubMed    
     
     
     June 2022
380. RUDYM D, Chang SH, Angel LF
     Characteristics and Outcomes of Patients With COVID-19-Associated ARDS Who Underwent Lung Transplant.
     JAMA. 2022;327:2454.
     PubMed    
     
     
     
381. MANERIKAR A, Budinger GRS, Bharat A
     Characteristics and Outcomes of Patients With COVID-19-Associated ARDS Who Underwent Lung Transplant-Reply.
     JAMA. 2022;327:2454-2455.
     PubMed    
     
     
     
382. CARDOSO CC, Rossi AD, Galliez RM, Faffe DS, et al
     Olfactory Dysfunction in Patients With Mild COVID-19 During Gamma, Delta, and Omicron Waves in Rio de Janeiro, Brazil.
     JAMA. 2022 Jun 24. pii: 2793811. doi: 10.1001/jama.2022.11006.
     PubMed    
     
     
     
383. ABBASI J
     COVID-19 mRNA Vaccine Booster During Pregnancy Increases Maternal and Fetal Antibodies.
     JAMA. 2022 Jun 22. pii: 2793740. doi: 10.1001/jama.2022.11145.
     PubMed    
     
     
     
384. RUBIN R
     Baricitinib Is First Approved COVID-19 Immunomodulatory Treatment.
     JAMA. 2022;327:2281.
     PubMed    
     
     
     
385. LARKIN HD
     mRNA COVID-19 Vaccine Booster After Inactivated Vaccine Primary Series.
     JAMA. 2022;327:2280.
     PubMed    
     
     
     
386. KLOMPAS M, Pandolfi MC, Nisar AB, Baker MA, et al
     Association of Omicron vs Wild-type SARS-CoV-2 Variants With Hospital-Onset SARS-CoV-2 Infections in a US Regional Hospital System.
     JAMA. 2022 Jun 15. pii: 2793582. doi: 10.1001/jama.2022.9609.
     PubMed    
     
     
     
387. HAMAD R, Galea S
     The Role of Health Care Systems in Bolstering the Social Safety Net to Address Health Inequities in the Wake of the COVID-19 Pandemic.
     JAMA. 2022 Jun 15. pii: 2793581. doi: 10.1001/jama.2022.10160.
     PubMed    
     
     
     
388. LARKIN HD
     Urine Test Detects SARS-CoV-2 Antibodies.
     JAMA. 2022;327:2182.
     PubMed    
     
     
     
389. FARMAKIOTIS D
     COVID-19 Treatments for Nonhospitalized Patients.
     JAMA. 2022;327:2247.
     PubMed    
     
     
     
390. CAYLEY WE JR
     COVID-19 Treatments for Nonhospitalized Patients.
     JAMA. 2022;327:2248.
     PubMed    
     
     
     
391. GANDHI RT, Malani PN, Del Rio C
     COVID-19 Treatments for Nonhospitalized Patients-Reply.
     JAMA. 2022;327:2248.
     PubMed    
     
     
     
392. KATZ SE, Edwards K
     Protecting Children Against Omicron.
     JAMA. 2022;327:2195-2197.
     PubMed    
     
     
     
393. JONES JM, Opsomer JD, Stone M, Benoit T, et al
     Updated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Estimates Based on Blood Donations, July 2020-December 2021.
     JAMA. 2022 Jun 13. pii: 2793517. doi: 10.1001/jama.2022.9745.
     PubMed    
     
     
     
394. RUBIN R
     From Positive to Negative to Positive Again-The Mystery of Why COVID-19 Rebounds in Some Patients Who Take Paxlovid.
     JAMA. 2022 Jun 8. pii: 2793357. doi: 10.1001/jama.2022.9925.
     PubMed    
     
     
     
395. DOWELL D, Lindsley WG, Brooks JT
     Reducing SARS-CoV-2 in Shared Indoor Air.
     JAMA. 2022 Jun 7. pii: 2793289. doi: 10.1001/jama.2022.9970.
     PubMed    
     
     
     
396. LARKIN HD
     Warning Against Counterfeit At-home COVID-19 Tests.
     JAMA. 2022;327:2067.
     PubMed    
     
     
     
397. LI Y
     Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave.
     JAMA. 2022;327:2147-2148.
     PubMed    
     
     
     
398. LATRONICO N, Rasulo FA, Piva S
     Outcomes Among Patients With 1-Year Survival After Intensive Care Unit Treatment for COVID-19.
     JAMA. 2022;327:2149.
     PubMed    
     
     
     
399. BAI W, Jackson T, Xiang YT
     Outcomes Among Patients With 1-Year Survival After Intensive Care Unit Treatment for COVID-19.
     JAMA. 2022;327:2148-2149.
     PubMed    
     
     
     
400. SEVIN CM, Ely EW
     Outcomes Among Patients With 1-Year Survival After Intensive Care Unit Treatment for COVID-19.
     JAMA. 2022;327:2149-2150.
     PubMed    
     
     
     
401. MASLO C, Toubkin M
     Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave-Reply.
     JAMA. 2022;327:2148.
     PubMed    
     
     
     
402. HEESAKKERS H, van den Boogaard M, Zegers M
     Outcomes Among Patients With 1-Year Survival After Intensive Care Unit Treatment for COVID-19-Reply.
     JAMA. 2022;327:2150-2151.
     PubMed    
     
     
     
403. VIJAY A, Yancy CW
     Resident Physician Wellness Postpandemic: How Does Healing Occur?
     JAMA. 2022;327:2077-2078.
     PubMed    
     
     
     
404. TAI CG, Maragakis LL, Connolly S, DiFiori J, et al
     Association Between COVID-19 Booster Vaccination and Omicron Infection in a Highly Vaccinated Cohort of Players and Staff in the National Basketball Association.
     JAMA. 2022 Jun 2. pii: 2793169. doi: 10.1001/jama.2022.9479.
     PubMed    
     
     
     
405. RUBIN R
     Challenges of Deciding Whether and How to Update COVID-19 Vaccines to Protect Against Variants.
     JAMA. 2022 Jun 1. pii: 2793149. doi: 10.1001/jama.2022.9367.
     PubMed    
     
     
     May 2022
406. DEL RIO C, Malani PN
     COVID-19 in 2022-The Beginning of the End or the End of the Beginning?
     JAMA. 2022 May 27. pii: 2793011. doi: 10.1001/jama.2022.9655.
     PubMed    
     
     
     
407. WEISS SR
     Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US.
     JAMA. 2022;327:2019-2020.
     PubMed    
     
     
     
408. PEREZ-FERNANDEZ XL, Fuset-Cabanes M, Hernandez-Platero L
     Noninvasive Respiratory Strategies and Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19.
     JAMA. 2022;327:2022-2023.
     PubMed    
     
     
     
409. YARNELL CJ, Sklar MC
     Noninvasive Respiratory Strategies and Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19.
     JAMA. 2022;327:2023.
     PubMed    
     
     
     
410. OSTER ME, Shay DK, Shimabukuro TT
     Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US-Reply.
     JAMA. 2022;327:2020-2021.
     PubMed    
     
     
     
411. COUPER K, Connolly BA, McAuley DF
     Noninvasive Respiratory Strategies and Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19-Reply.
     JAMA. 2022;327:2023-2024.
     PubMed    
     
     
     
412. KUEHN BM
     Cardiac Complications More Common After COVID-19 Than Vaccination.
     JAMA. 2022;327:1951.
     PubMed    
     
     
     
413. FAUST JS, Du C, Liang C, Mayes KD, et al
     Excess Mortality in Massachusetts During the Delta and Omicron Waves of COVID-19.
     JAMA. 2022 May 20. pii: 2792738. doi: 10.1001/jama.2022.8045.
     PubMed    
     
     
     
414. LEVY N, Koppel JH, Kaplan O, Yechiam H, et al
     Severity and Incidence of Multisystem Inflammatory Syndrome in Children During 3 SARS-CoV-2 Pandemic Waves in Israel.
     JAMA. 2022 May 19. pii: 2792718. doi: 10.1001/jama.2022.8025.
     PubMed    
     
     
     
415. RUBIN R
     SARS-CoV-2 RNA Can Persist in Stool Months After Respiratory Tract Clears Virus.
     JAMA. 2022 May 18. pii: 2792688. doi: 10.1001/jama.2022.7892.
     PubMed    
     
     
     
416. BELLANDI D, Voelker R
     New White House COVID-19 Leader on What's Next.
     JAMA. 2022 May 18. pii: 2792686. doi: 10.1001/jama.2022.8541.
     PubMed    
     
     
     
417. RUBIN R
     First Breathalyzer Test to Diagnose COVID-19.
     JAMA. 2022;327:1860.
     PubMed    
     
     
     
418. BEZERRA MF
     Rapid Antigen Tests for SARS-CoV-2.
     JAMA. 2022;327:1925-1926.
     PubMed    
     
     
     
419. GANS JS, Goldfarb A, Rosella L
     Rapid Antigen Tests for SARS-CoV-2-Reply.
     JAMA. 2022;327:1926.
     PubMed    
     
     
     
420. SHIROKY-KOCHAVI J
     The Pandemic Determinants of Health.
     JAMA. 2022;327:1869.
     PubMed    
     
     
     
421. ALHAZZANI W, Parhar KKS, Weatherald J, Al Duhailib Z, et al
     Effect of Awake Prone Positioning on Endotracheal Intubation in Patients With COVID-19 and Acute Respiratory Failure: A Randomized Clinical Trial.
     JAMA. 2022 May 15. pii: 2792506. doi: 10.1001/jama.2022.7993.
     PubMed     Abstract available
     
     
     
422. FLEMING-DUTRA KE, Britton A, Shang N, Derado G, et al
     Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.
     JAMA. 2022 May 13. pii: 2792524. doi: 10.1001/jama.2022.7493.
     PubMed     Abstract available
     
     
     
423. DORABAWILA V, Hoefer D, Bauer UE, Bassett MT, et al
     Risk of Infection and Hospitalization Among Vaccinated and Unvaccinated Children and Adolescents in New York After the Emergence of the Omicron Variant.
     JAMA. 2022 May 13. pii: 2792525. doi: 10.1001/jama.2022.7319.
     PubMed    
     
     
     
424. HOURY DE, Simon TR, Crosby AE
     Firearm Homicide and Suicide During the COVID-19 Pandemic: Implications for Clinicians and Health Care Systems.
     JAMA. 2022 May 10. pii: 2792080. doi: 10.1001/jama.2022.6924.
     PubMed    
     
     
     
425. LARKIN HD
     Four Vaccine Doses Prevented Severe Omicron COVID-19 Better Than 3.
     JAMA. 2022;327:1748.
     PubMed    
     
     
     
426. LARKIN HD
     Two mRNA COVID-19 Vaccines Stimulate Different Immune Responses.
     JAMA. 2022;327:1748.
     PubMed    
     
     
     
427. MANGURIAN C, Fitelson EM, Epel E
     COVID-19 and Lessons to Improve Preparedness for the Next Pandemic.
     JAMA. 2022;327:1822-1823.
     PubMed    
     
     
     
428. CHEN J, Al-Azzawi ZAM, Taifour T
     Testing, Surveillance, and Mitigation Strategies for COVID-19.
     JAMA. 2022;327:1824-1825.
     PubMed    
     
     
     
429. NUZZO JB, Gostin LO
     COVID-19 and Lessons to Improve Preparedness for the Next Pandemic-Reply.
     JAMA. 2022;327:1823.
     PubMed    
     
     
     
430. EMANUEL EJ, Michaels D, Bright RA
     Testing, Surveillance, and Mitigation Strategies for COVID-19-Reply.
     JAMA. 2022;327:1825.
     PubMed    
     
     
     
431. KUEHN BM
     mRNA Booster Improves a COVID-19 Vaccine's Effectiveness.
     JAMA. 2022;327:1749.
     PubMed    
     
     
     
432. GANDJOUR A
     Strategy for the "New Normal" of Life With COVID.
     JAMA. 2022;327:1823-1824.
     PubMed    
     
     
     
433. EMANUEL EJ, Osterholm M, Gounder CR
     Strategy for the "New Normal" of Life With COVID-Reply.
     JAMA. 2022;327:1824.
     PubMed    
     
     
     
434. SLOMSKI A
     Studies Examine Risk of Hearing Loss After COVID-19 Vaccination.
     JAMA. 2022;327:1641.
     PubMed    
     
     
     
435. MARKS P, Woodcock J, Califf R
     COVID-19 Vaccination-Becoming Part of the New Normal.
     JAMA. 2022 May 2. pii: 2792030. doi: 10.1001/jama.2022.7469.
     PubMed    
     
     
     
436. MCCLYMONT E, Albert AY, Alton GD, Boucoiran I, et al
     Association of SARS-CoV-2 Infection During Pregnancy With Maternal and Perinatal Outcomes.
     JAMA. 2022 May 2. pii: 2792031. doi: 10.1001/jama.2022.5906.
     PubMed     Abstract available
     
     
     April 2022
437. RUBIN R
     The COVID-19 Pandemic Rages on for People Who Are Immunocompromised.
     JAMA. 2022 Apr 27. pii: 2791868. doi: 10.1001/jama.2022.7281.
     PubMed    
     
     
     
438. SURAN M
     White Individuals Experience Less COVID-19-Related Discrimination.
     JAMA. 2022;327:1538.
     PubMed    
     
     
     
439. KUEHN BM
     COVID-19 Vaccine Effectiveness in Youth Varies by Age, Variant.
     JAMA. 2022;327:1540.
     PubMed    
     
     
     
440. PETTY LA, Malani PN
     Oral Antiviral Medications for COVID-19.
     JAMA. 2022 Apr 25. pii: 2791780. doi: 10.1001/jama.2022.6876.
     PubMed    
     
     
     
441. RAZZAGHI H, Meghani M, Crane B, Ellington S, et al
     Receipt of COVID-19 Booster Dose Among Fully Vaccinated Pregnant Individuals Aged 18 to 49 Years by Key Demographics.
     JAMA. 2022 Apr 22. pii: 2791659. doi: 10.1001/jama.2022.6834.
     PubMed    
     
     
     
442. SURAN M
     Stagnant US Mammography Rates and the Influence of COVID-19.
     JAMA. 2022 Apr 20. pii: 2791573. doi: 10.1001/jama.2022.4295.
     PubMed    
     
     
     
443. LARKIN HD
     Global COVID-19 Death Toll May Be Triple the Reported Deaths.
     JAMA. 2022;327:1438.
     PubMed    
     
     
     
444. LARKIN HD
     WHO Urges Monitoring SARS-CoV-2 in Wildlife to Prevent Animal Reservoirs.
     JAMA. 2022;327:1438.
     PubMed    
     
     
     
445. LARKIN HD
     Fractionating COVID-19 Vaccine Doses May Save Lives.
     JAMA. 2022;327:1438.
     PubMed    
     
     
     
446. WOLFSON AR, Freeman EE, Blumenthal KG
     Urticaria 12 Days After COVID-19 mRNA Booster Vaccination.
     JAMA. 2022 Apr 14. pii: 2791317. doi: 10.1001/jama.2022.5247.
     PubMed    
     
     
     
447. ABBASI J
     Large US Study Examines First 6 Months of COVID-19 Vaccine Safety Data.
     JAMA. 2022;327:1323.
     PubMed    
     
     
     
448. KUEHN BM
     Myocarditis Adverse Event Less Common After COVID-19 Vaccine Booster.
     JAMA. 2022;327:1324.
     PubMed    
     
     
     
449. ABBASI J
     Vaccine Booster Dose Appears to Reduce Omicron Hospitalizations.
     JAMA. 2022;327:1323.
     PubMed    
     
     
     
450. TSAY SV, Bartoces M, Gouin K, Kabbani S, et al
     Antibiotic Prescriptions Associated With COVID-19 Outpatient Visits Among Medicare Beneficiaries, April 2020 to April 2021.
     JAMA. 2022 Apr 8. pii: 2791077. doi: 10.1001/jama.2022.5471.
     PubMed    
     
     
     
451. BRADLEY MC, Perez-Vilar S, Chillarige Y, Dong D, et al
     Systemic Corticosteroid Use for COVID-19 in US Outpatient Settings From April 2020 to August 2021.
     JAMA. 2022 Apr 8. pii: 2791078. doi: 10.1001/jama.2022.4877.
     PubMed    
     
     
     
452. SLOMSKI A
     At-home COVID-19 Test Instructions Frequently Misinterpreted.
     JAMA. 2022;327:1218.
     PubMed    
     
     
     
453. SLOMSKI A
     Maternal COVID-19 Vaccine Safe for Infants.
     JAMA. 2022;327:1218.
     PubMed    
     
     
     
454. NISSEN SE, Wolski K, Balog C, Swerdlow DI, et al
     Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels.
     JAMA. 2022 Apr 3. pii: 2790912. doi: 10.1001/jama.2022.5050.
     PubMed     Abstract available
     
     
     
455. NATTINO G, Castiglioni S, Cereda D, Della Valle PG, et al
     Association Between SARS-CoV-2 Viral Load in Wastewater and Reported Cases, Hospitalizations, and Vaccinations in Milan, March 2020 to November 2021.
     JAMA. 2022 Apr 1. pii: 2790911. doi: 10.1001/jama.2022.4908.
     PubMed    
     
     
     March 2022
456. SAGE WM, Yang YT
     Reducing "COVID-19 Misinformation" While Preserving Free Speech.
     JAMA. 2022 Mar 31. pii: 2790859. doi: 10.1001/jama.2022.4231.
     PubMed    
     
     
     
457. KHARBANDA EO, Vazquez-Benitez G
     COVID-19 mRNA Vaccines During Pregnancy: New Evidence to Help Address Vaccine Hesitancy.
     JAMA. 2022 Mar 24. pii: 2790610. doi: 10.1001/jama.2022.2459.
     PubMed    
     
     
     
458. ADHIKARI EH, MacDonald L, SoRelle JA, Morse J, et al
     COVID-19 Cases and Disease Severity in Pregnancy and Neonatal Positivity Associated With Delta (B.1.617.2) and Omicron (B.1.1.529) Variant Predominance.
     JAMA. 2022 Mar 24. pii: 2790609. doi: 10.1001/jama.2022.4356.
     PubMed    
     
     
     
459. MAGNUS MC, Ortqvist AK, Dahlqwist E, Ljung R, et al
     Association of SARS-CoV-2 Vaccination During Pregnancy With Pregnancy Outcomes.
     JAMA. 2022 Mar 24. pii: 2790608. doi: 10.1001/jama.2022.3271.
     PubMed     Abstract available
     
     
     
460. FELL DB, Dhinsa T, Alton GD, Torok E, et al
     Association of COVID-19 Vaccination in Pregnancy With Adverse Peripartum Outcomes.
     JAMA. 2022 Mar 24. pii: 2790607. doi: 10.1001/jama.2022.4255.
     PubMed     Abstract available
     
     
     
461. ABBASI J
     Even Mild COVID-19 May Change the Brain.
     JAMA. 2022 Mar 23. pii: 2790595. doi: 10.1001/jama.2022.4507.
     PubMed    
     
     
     
462. SURAN M
     COVID-19 Booster Shot Data Now Available From Nursing Homes.
     JAMA. 2022;327:1117.
     PubMed    
     
     
     
463. BRADBURY CA, Lawler PR, Stanworth SJ, McVerry BJ, et al
     Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
     JAMA. 2022 Mar 22. pii: 2790488. doi: 10.1001/jama.2022.2910.
     PubMed     Abstract available
     
     
     
464. CONNORS JM, Ridker PM
     Thromboinflammation and Antithrombotics in COVID-19: Accumulating Evidence and Current Status.
     JAMA. 2022 Mar 22. pii: 2790489. doi: 10.1001/jama.2022.2361.
     PubMed    
     
     
     
465. STEAD W
     One Person.
     JAMA. 2022;327:1131-1132.
     PubMed    
     
     
     
466. WHITE AM, Castle IP, Powell PA, Hingson RW, et al
     Alcohol-Related Deaths During the COVID-19 Pandemic.
     JAMA. 2022 Mar 18. pii: 2790491. doi: 10.1001/jama.2022.4308.
     PubMed    
     
     
     
467. LIEBOWITZ JE, Konig MF
     Joint Pain in a Woman Wearing a Face Mask.
     JAMA. 2022 Mar 17. pii: 2790422. doi: 10.1001/jama.2022.2644.
     PubMed    
     
     
     
468. FRIEDENSOHN L, Levin D, Fadlon-Derai M, Gershovitz L, et al
     Myocarditis Following a Third BNT162b2 Vaccination Dose in Military Recruits in Israel.
     JAMA. 2022 Mar 17. pii: 2790421. doi: 10.1001/jama.2022.4425.
     PubMed    
     
     
     
469. LI J, Pavlov I, Ehrmann S
     High-Flow Oxygen vs Conventional Oxygen and Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19.
     JAMA. 2022;327:1092.
     PubMed    
     
     
     
470. OSPINA-TASCON GA, Martinez D, Gempeler A
     High-Flow Oxygen vs Conventional Oxygen and Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19-Reply.
     JAMA. 2022;327:1092-1093.
     PubMed    
     
     
     
471. LARKIN HD
     WHO Releases Report on Maintaining Health Services During COVID-19.
     JAMA. 2022;327:1019.
     PubMed    
     
     
     
472. GUPTA A, Gonzalez-Rojas Y, Juarez E, Crespo Casal M, et al
     Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
     JAMA. 2022 Mar 14. pii: 2790246. doi: 10.1001/jama.2022.2832.
     PubMed     Abstract available
     
     
     
473. COREY L, Corbett-Detig R, Beyrer C
     Expanding Efforts and Support to Respond to the HIV and COVID-19 Intersecting Pandemics.
     JAMA. 2022 Mar 11. pii: 2790239. doi: 10.1001/jama.2022.3517.
     PubMed    
     
     
     
474. RUBIN R
     Once Viewed as a Promising COVID-19 Treatment, Convalescent Plasma Falls Out of Favor.
     JAMA. 2022 Mar 9. pii: 2790074. doi: 10.1001/jama.2022.3214.
     PubMed    
     
     
     
475. KUEHN BM
     Racial and Ethnic, Gender Disparities Seen in LGBT COVID-19 Vaccination Rates.
     JAMA. 2022;327:910.
     PubMed    
     
     
     
476. JORGENSEN SB, Nygard K, Kacelnik O, Telle K, et al
     Secondary Attack Rates for Omicron and Delta Variants of SARS-CoV-2 in Norwegian Households.
     JAMA. 2022 Mar 7. pii: 2789920. doi: 10.1001/jama.2022.3780.
     PubMed    
     
     
     
477. ADASHI EY, Cohen IG
     SARS-CoV-2 Laboratory-Developed Tests: Integrity Restored.
     JAMA. 2022 Mar 4. pii: 2789917. doi: 10.1001/jama.2022.3382.
     PubMed    
     
     
     
478. TONELLI M, Warick R
     Focusing on the Needs of People With Hearing Loss During the COVID-19 Pandemic and Beyond.
     JAMA. 2022 Mar 3. pii: 2789772. doi: 10.1001/jama.2022.3026.
     PubMed    
     
     
     
479. ABBASI J
     The COVID Heart-One Year After SARS-CoV-2 Infection, Patients Have an Array of Increased Cardiovascular Risks.
     JAMA. 2022 Mar 2. pii: 2789793. doi: 10.1001/jama.2022.2411.
     PubMed    
     
     
     
480. SLOMSKI A
     Metabolic Surgery Associated With Less Severe COVID-19.
     JAMA. 2022;327:804.
     PubMed    
     
     
     
481. GOMES T, Campbell TJ, Kitchen SA, Garg R, et al
     Association Between Increased Dispensing of Opioid Agonist Therapy Take-Home Doses and Opioid Overdose and Treatment Interruption and Discontinuation.
     JAMA. 2022;327:846-855.
     PubMed     Abstract available
     
     
     
482. BROOKS MM, Wisniewski SR
     Assessing Unexpected Circumstances That Lead to Modifications in Clinical Trial Design, Conduct, or Analysis: Application of the CONSERVE Reporting Guideline.
     JAMA. 2022;327:868-869.
     PubMed    
     
     
     October 2021
483. RADWANY S
     Our Best Judgment.
     JAMA. 2021;326:1373-1374.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO COVID-19 is free of charge.